Inguinal hernia, unilateral

HERING_UNILATERAL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K41.3, K41.4, K41.9 Cause of death: ICD-10 — K41.3, K41.4, K41.9 2 out of 7 registries used, show all original rules.	1091
4. Check minimum number of events None	1091
5. Include endpoints None	1091
6. Filter based on genotype QC (FinnGen only)	1059

Control definitions (FinnGen only)

Control exclude: K11_HERNIA

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	HERING_UNILATERAL
CONTROL_EXCLUDE	K11_HERNIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K41[3-9]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K41[3-9]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Inguinal hernia, unilateral based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8437	5168	3231
Only index persons	7546	4656	2890
Unadjusted period prevalence (%)
Whole population	0.13	0.15	0.09
Only index persons	0.15	0.17	0.11
Median age at first event (years)
Whole population	64.81	66.55	61.92
Only index persons	62.89	64.41	60.44

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1059	628	431
Unadjusted period prevalence (%)	0.21	0.22	0.20
Median age at first event (years)	61.92	60.59	63.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1091: Matched controls
10910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K41.3

ICD-10 Finland

Unilateral or unspecified femoral hernia, with obstruction, without gangrene

+∞

307.7

303

K41.9

ICD-10 Finland

Unilateral or unspecified femoral hernia, without obstruction or gangrene

+∞

307.7

793

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

299.5

307.7

572

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

2434.2

307.7

332

JAC30

NOMESCO Finland

Repair of femoral hernia using prosthetic material

+∞

188.1

175

JAC10

NOMESCO Finland

Repair of femoral hernia

+∞

177.0

165

JAB11

NOMESCO Finland

Laparoscopic repair of inguinal hernia

1798.5

160.5

152

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

55.3

143.9

K40.3

ICD-10 Finland

Unilateral or unspecified inguinal hernia, with obstruction, without gangrene

399.8

143.5

141

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

79.3

138.1

K40

ICD-10 Finland

Inguinal hernia

40.5

129.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

20.5

123.6

D89

ICPC

Inguinal hernia

65.9

123.3

JAC11

NOMESCO Finland

Laparoscopic repair of femoral hernia

+∞

99.5

K40.2

ICD-10 Finland

Bilateral inguinal hernia, without obstruction or gangrene

116.6

70.9

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

11.4

68.5

JAB12

NOMESCO Finland

Laparoscopic repair of inguinal hernia, TEP

+∞

63.1

K41.4

ICD-10 Finland

Unilateral or unspecified femoral hernia, with gangrene

+∞

61.0

JFB00

NOMESCO Finland

Partial resection of small intestine

12.6

60.4

JAF10

NOMESCO Finland

Repair of umbilical hernia

26.6

59.1

JAB10

NOMESCO Finland

Repair of inguinal hernia

296.2

55.7

6123

FHL

Radical surgery

130.9

47.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.7

43.0

306

1383

55099

ICD-8 Finland

Inguinal hernia without mention of obstruction

+∞

43.0

JAC12

NOMESCO Finland

Laparoscopic repair of femoral hernia, TEP

+∞

40.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

33.6

435

2521

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

+∞

32.5

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

29.4

185

773

ZXD05

NOMESCO Finland

Urgent procedure

2.1

27.1

378

2216

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

+∞

25.1

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

255.7

24.8

5509B

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]

+∞

24.0

ZXA00

NOMESCO Finland

Right side

2.0

23.8

339

1984

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

+∞

23.0

5509A

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,MEDIALIS]

+∞

21.9

WX320

NOMESCO Finland

Spinalanesthesy

2.0

20.3

310

1843

ZXA05

NOMESCO Finland

Left side

1.9

19.6

308

1845

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

19.6

297

1758

K41

ICD-10 Finland

Femoral hernia

107.0

19.6

N02BE01

ATC

paracetamol; systemic, rectal

2.6

19.4

991

8638

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

19.0

130

561

K40.4

ICD-10 Finland

Unilateral or unspecified inguinal hernia, with gangrene

+∞

17.8

WX402

NOMESCO Finland

General anaesthesia

1.9

17.4

253

1469

SPAT1153

SPAT

Removal of sutures

1.8

17.3

369

2418

JAH01

NOMESCO Finland

Laparoscopy

3.3

16.8

201

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

7.4

16.6

WX704

NOMESCO Finland

Intubation

2.6

16.5

105

437

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

15.9

405

2777

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

15.8

152

758

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

+∞

15.7

S18

ICPC

Laceration/cut

1.7

15.3

531

3946

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

15.2

319

2067

UJF32

NOMESCO Finland

Coloscopy

1.8

14.2

291

1867

JAB91

NOMESCO Finland

Repair of recurrent inguinal hernia, endoscopy

+∞

13.6

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

+∞

13.6

K41.2

ICD-10 Finland

Bilateral femoral hernia, without obstruction or gangrene

+∞

13.6

JAC96

NOMESCO Finland

Other repair of femoral hernia

+∞

13.6

PHD99

NOMESCO Finland

Resection of other vein

2.6

13.6

309

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

13.5

728

5968

JAD10

NOMESCO Finland

Repair of incisional hernia

141.7

13.5

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

6.4

13.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

13.2

544

4165

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

13.1

142

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

12.7

221

1347

B01AB05

ATC

enoxaparin; parenteral

1.7

12.7

355

2466

JAB96

NOMESCO Finland

Other repair of inguinal hernia

+∞

12.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

12.1

104

495

A02BC02

ATC

pantoprazole; systemic

1.6

12.0

740

6171

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

11.9

293

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

11.5

442

3296

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

+∞

11.5

6124

FHL

Radical cutting and plastic with foreign material

121.2

11.4

SPAT1263

SPAT

Sampling

1.6

11.1

429

3198

N02AX02

ATC

tramadol; systemic, rectal

1.6

11.0

461

3496

D06

ICPC

Abdominal pain localized other

2.2

11.0

473

103

Kela drug reimbursment

Diabetes, insulin-treated

0.5

10.7

131

2238

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

10.5

408

JAB97

NOMESCO Finland

Other laparoscopic repair of inguinal hernia

+∞

10.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

10.3

209

1323

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

10.3

238

1563

M79.6

ICD-10 Finland

Pain in limb

1.5

10.2

463

3556

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

10.2

373

SPAT1301

SPAT

No procedures

1.6

10.2

333

2379

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

9.8

447

3430

D91

ICPC

Abdominal hernia other

13.5

9.7

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

9.6

402

M54.5

ICD-10 Finland

Low back pain

1.5

9.5

365

2694

PHD76

NOMESCO Finland

Resection of long saphenous vein

2.5

9.5

243

G04CA02

ATC

tamsulosin; oral

1.6

9.3

249

1693

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

9.1

240

1623

H02AB06

ATC

prednisolone; systemic

1.5

9.1

500

3965

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

9.0

209

1368

R03AC02

ATC

salbutamol; inhalant

1.5

9.0

554

4488

N03AX16

ATC

[U] pregabalin

1.6

8.9

246

1680

K62.3

ICD-10 Finland

Rectal prolapse

4.3

8.9

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.9

8.9

113

620

A02BC05

ATC

esomeprazole; systemic

1.5

8.8

410

3138

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

8.8

115

638

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

8.8

310

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

8.7

285

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

8.7

174

1095

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

50.4

8.7

J01CA04

ATC

amoxicillin; systemic

1.5

8.6

822

7244

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

8.5

208

1379

N03AX12

ATC

[U] gabapentin; oral

1.7

8.4

175

1113

5509X

ICD-9 Finland

Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,ALIA SEU NUD]

+∞

8.3

K40.0

ICD-10 Finland

Bilateral inguinal hernia, with obstruction, without gangrene

+∞

8.3

JAB93

NOMESCO Finland

Repair of recurrent inguinal hernia, implantation

+∞

8.3

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.1

8.3

384

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

8.3

126

733

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

8.1

142

860

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

8.1

301

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

33.6

8.1

J01MA02

ATC

ciprofloxacin; systemic

1.5

8.1

405

3134

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

8.1

237

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

8.1

189

1239

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

8.0

376

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.9

8.0

A10BA02

ATC

metformin; oral

0.6

8.0

158

2398

L17

ICPC

Foot/toe symptom/complaint

1.5

7.9

315

2326

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.9

7.9

132

M25.5

ICD-10 Finland

Pain in joint

1.5

7.9

328

2444

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.7

7.9

139

845

J01DB01

ATC

cefalexin; oral

1.5

7.8

839

7481

R52.2

ICD-10 Finland

Other chronic pain

2.5

7.7

192

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.3

7.7

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

7.7

140

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

7.6

300

2207

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

7.6

430

3397

SPAT1260

SPAT

Consultation of another employee

1.6

7.5

179

1178

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

7.5

196

1320

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

7.4

280

2042

L12

ICPC

Hand/finger symptom/complaint

1.6

7.4

179

1183

ZXD20

NOMESCO Finland

Day surgery

1.7

7.4

130

790

S22.3

ICD-10 Finland

Fracture of rib

2.0

7.3

453

JBB01

NOMESCO Finland

Laparoscopic repair of paraoesophageal hernia

+∞

7.3

K41.1

ICD-10 Finland

Bilateral femoral hernia, with gangrene

+∞

7.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

7.3

163

1055

N43.4

ICD-10 Finland

Spermatocele

3.7

7.2

ZXE00

NOMESCO Finland

One hour or less

1.4

7.1

382

2981

R52.9

ICD-10 Finland

Pain, unspecified

1.8

7.1

106

614

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

7.1

132

815

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

7.0

185

1245

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

7.0

497

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

6.9

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

6.9

160

JAH00

NOMESCO Finland

Laparotomy

2.7

6.9

131

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.6

6.8

133

2037

A98

ICPC

Health maint/preventive medicine

1.8

6.8

1004

9421

SPAT1312

SPAT

General health counselling

1.5

6.8

299

2243

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

6.8

569

UKC02

NOMESCO Finland

Cystoscopy

1.6

6.8

167

1107

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.6

6.7

124

1926

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

6.7

373

2923

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

6.6

373

2924

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.0

6.6

368

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

6.6

679

5895

H13

ICPC

Plugged feeling ear

1.5

6.6

209

1466

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.4

6.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

6.5

427

K10.3

ICD-10 Finland

Alveolitis of jaws

2.3

6.5

208

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

6.5

175

1185

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

6.4

428

3453

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

6.4

369

2903

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

6.3

120

743

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

6.3

319

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

6.3

410

3292

AA1AD

NOMESCO Finland

CT of head and brain

1.4

6.3

312

2390

JAE10

NOMESCO Finland

Repair of epigastric hernia

+∞

6.3

K41.0

ICD-10 Finland

Bilateral femoral hernia, with obstruction, without gangrene

+∞

6.3

JAC97

NOMESCO Finland

Other laparoscopic repair of femoral hernia

+∞

6.3

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.6

6.2

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

6.2

151

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.3

6.2

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.5

6.2

145

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

6.1

189

JN2AE, ,

SPAT

8.7

6.1

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.0

6.0

303

T90

ICPC

Diabetes non-insulin dependent

0.6

6.0

130

1948

J01AA02

ATC

doxycycline; systemic

1.4

6.0

802

7216

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

General Surgery
2 [38004447]

5.7e-01

1.3e+00

2.4e+00

7.7e+00

2.7e+00

1.5e+00

6.1e-01

cases:27.60%

controls:17.78%

cases:18.12%

controls:5.86%

cases:9.66%

controls:0.96%

cases:49.86%

controls:0.05%

cases:11.15%

controls:0.80%

cases:22.49%

controls:5.81%

cases:27.60%

controls:17.13%

300

1932

787

8937

197

637

890

10232

105

104

982

10765

542

545

10864

121

964

10765

237

614

817

9952

252

1541

661

7453

Upper gastrointestinal surgery
106 [44777669]

8.5e-01

2.1e+00

3.1e+00

—

3.4e+00

2.5e+00

1.2e+00

cases:14.35%

controls:6.66%

cases:17.30%

controls:2.44%

cases:10.67%

controls:0.52%

—

cases:13.18%

controls:0.49%

cases:24.76%

controls:2.71%

cases:21.58%

controls:7.66%

156

724

931

10145

188

265

899

10604

116

971

10813

—

143

942

10799

261

286

793

10280

197

689

716

8305

Outpatient Hospital
22 [8756]

4.4e-01

6.8e-01

9.1e-01

6.5e+00

1.9e+00

1.2e+00

5.8e-01

cases:32.93%

controls:23.94%

cases:13.43%

controls:7.26%

cases:2.48%

controls:1.01%

cases:30.73%

controls:0.06%

cases:6.36%

controls:1.00%

cases:19.17%

controls:6.81%

cases:32.53%

controls:21.24%

358

2602

729

8267

146

789

941

10080

110

1060

10759

334

753

10862

108

1016

10744

202

720

852

9846

297

1910

616

7084

Inpatient Hospital
21 [8717]

3.5e-01

5.2e-01

1.1e+00

6.4e+00

2.0e+00

9.4e-01

5.2e-01

cases:40.02%

controls:32.05%

cases:18.12%

controls:11.63%

cases:4.88%

controls:1.69%

cases:34.22%

controls:0.08%

cases:10.41%

controls:1.58%

cases:23.53%

controls:10.71%

cases:39.76%

controls:28.27%

435

3483

652

7386

197

1264

890

9605

184

1034

10685

372

715

10860

113

171

972

10681

248

1132

806

9434

363

2543

550

6451

Emergency Room Visit
ER [9203]

3.3e-01

5.9e-01

1.9e+00

6.1e+00

1.7e+00

6.6e-01

3.8e-01

cases:36.98%

controls:29.73%

cases:18.58%

controls:11.19%

cases:8.10%

controls:1.36%

cases:21.53%

controls:0.06%

cases:7.65%

controls:1.46%

cases:19.17%

controls:10.90%

cases:40.74%

controls:32.08%

402

3231

685

7638

202

1216

885

9653

148

999

10721

234

853

10862

158

1002

10694

202

1152

852

9414

372

2885

541

6109

Pain localized to other parts of lower abdomen
R10.3 [45534426]

7.1e-01

2.0e+00

2.8e+00

1.0e+50

2.6e+00

2.0e+00

8.5e-01

cases:4.51%

controls:2.27%

cases:5.06%

controls:0.69%

cases:1.56%

controls:0.10%

cases:1.01%

controls:0.00%

cases:0.65%

controls:0.05%

cases:5.03%

controls:0.70%

cases:6.24%

controls:2.78%

247

1038

10622

1032

10794

1070

10858

1076

10869

1078

10847

1001

10492

250

856

8744

Other and unspecified abdominal pain
R10.4 [45568113]

7.7e-01

1.3e+00

3.0e+00

1.0e+50

2.0e+00

1.7e+00

9.4e-01

cases:8.74%

controls:4.25%

cases:4.97%

controls:1.34%

cases:2.76%

controls:0.15%

cases:1.84%

controls:0.00%

cases:1.29%

controls:0.18%

cases:6.26%

controls:1.22%

cases:11.61%

controls:4.88%

462

992

10407

146

1033

10723

1057

10853

1067

10869

1071

10833

129

988

10437

106

439

807

8555

Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]

3.2e+00

—

3.1e+00

3.3e+00

cases:2.30%

controls:0.09%

—

cases:1.04%

controls:0.05%

cases:1.86%

controls:0.07%

1062

10859

—

1043

10561

896

8988

Unilateral or unspecified inguinal hernia, without obstruction or gangrene
K40.9 [45543307]

5.2e+00

—

1.0e+50

—

4.2e+00

cases:7.91%

controls:0.05%

—

cases:11.04%

controls:0.00%

cases:11.04%

controls:0.00%

cases:5.53%

controls:0.00%

—

cases:7.67%

controls:0.12%

1001

10864

—

120

967

10869

120

967

10869

1025

10852

—

843

8983

Outpatient Visit
OP [9202]

4.0e-01

6.2e-01

9.4e-01

5.0e+00

8.8e-01

8.0e-01

6.2e-01

cases:73.23%

controls:64.78%

cases:61.27%

controls:45.89%

cases:21.25%

controls:9.53%

cases:39.10%

controls:0.44%

cases:20.37%

controls:9.57%

cases:64.80%

controls:45.18%

cases:85.10%

controls:75.39%

796

7041

291

3828

666

4988

421

5881

231

1036

856

9833

425

662

10821

221

1038

864

9814

683

4774

371

5792

777

6781

136

2213

More than one and less than three hours
ZXE10 [2001311401]

5.0e-01

7.8e-01

1.6e+00

1.0e+50

2.7e+00

1.7e+00

8.0e-01

cases:7.73%

controls:4.84%

cases:2.94%

controls:1.37%

cases:0.74%

controls:0.15%

cases:7.45%

controls:0.00%

cases:2.12%

controls:0.14%

cases:5.31%

controls:1.05%

cases:8.76%

controls:4.14%

526

1003

10343

149

1055

10720

1079

10853

1006

10869

1062

10837

111

998

10455

372

833

8622

ibuprofen
R02AX02 [1588667]

3.9e-01

4.1e-01

4.3e-01

4.0e+00

2.0e+00

6.9e-01

3.8e-01

cases:38.73%

controls:30.03%

cases:18.58%

controls:13.18%

cases:3.13%

controls:2.05%

cases:2.58%

controls:0.05%

cases:13.46%

controls:2.01%

cases:22.68%

controls:12.84%

cases:38.88%

controls:30.34%

421

3264

666

7605

202

1433

885

9436

223

1053

10646

1059

10864

146

218

939

10634

239

1357

815

9209

355

2729

558

6265

ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]

3.9e-01

4.1e-01

4.3e-01

4.0e+00

2.0e+00

6.9e-01

3.8e-01

cases:38.73%

controls:30.03%

cases:18.58%

controls:13.18%

cases:3.13%

controls:2.05%

cases:2.58%

controls:0.05%

cases:13.46%

controls:2.01%

cases:22.68%

controls:12.84%

cases:38.88%

controls:30.34%

421

3264

666

7605

202

1433

885

9436

223

1053

10646

1059

10864

146

218

939

10634

239

1357

815

9209

355

2729

558

6265

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

5.4e-03

2.0e-01

1.1e+00

3.9e+00

1.5e+00

3.3e-01

2.8e-01

cases:21.25%

controls:21.16%

cases:16.93%

controls:14.31%

cases:7.64%

controls:2.68%

cases:8.92%

controls:0.19%

cases:11.80%

controls:2.80%

cases:18.79%

controls:14.29%

cases:37.13%

controls:30.84%

231

2300

856

8569

184

1555

903

9314

291

1004

10578

990

10848

128

304

957

10548

198

1510

856

9056

339

2774

574

6220

Right side
ZXA00 [2001311346]

5.2e-01

9.5e-01

1.6e+00

—

3.1e+00

1.8e+00

7.8e-01

cases:5.80%

controls:3.51%

cases:2.30%

controls:0.90%

cases:0.55%

controls:0.11%

—

cases:1.38%

controls:0.06%

cases:4.55%

controls:0.78%

cases:7.12%

controls:3.40%

382

1024

10487

1062

10771

1081

10857

—

1070

10845

1006

10484

306

848

8688

INR in Blood by Coagulation assay
34714-6 [3032080]

5.4e-02

3.3e-01

9.2e-01

4.2e+00

9.1e-01

5.3e-01

4.9e-01

cases:8.56%

controls:8.14%

cases:6.62%

controls:4.83%

cases:3.40%

controls:1.38%

cases:3.04%

controls:0.05%

cases:3.59%

controls:1.48%

cases:7.69%

controls:4.67%

cases:16.43%

controls:10.78%

885

994

9984

525

1015

10344

150

1050

10719

1054

10864

161

1046

10691

493

973

10073

150

970

763

8024

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

2.3e-01

3.6e-01

3.0e+00

1.0e+50

2.5e+00

1.1e+00

4.0e-01

cases:8.19%

controls:6.63%

cases:4.05%

controls:2.86%

cases:6.44%

controls:0.33%

cases:4.88%

controls:0.00%

cases:3.78%

controls:0.33%

cases:7.31%

controls:2.54%

cases:11.94%

controls:8.34%

721

998

10148

311

1043

10558

1017

10833

1034

10869

1044

10816

268

977

10298

109

750

804

8244

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

1.4e-01

2.8e-01

1.1e+00

4.3e+00

9.5e-01

3.0e-01

3.5e-01

cases:9.29%

controls:8.15%

cases:5.52%

controls:4.23%

cases:2.67%

controls:0.88%

cases:3.31%

controls:0.05%

cases:2.40%

controls:0.94%

cases:5.98%

controls:4.49%

cases:15.33%

controls:11.36%

101

886

986

9983

460

1027

10409

1058

10773

1051

10864

102

1059

10750

474

991

10092

140

1022

773

7972

CBC panel - Blood by Automated count
58410-2 [40761511]

4.6e-02

1.9e-01

1.4e+00

3.4e+00

1.5e+00

3.5e-01

1.7e-01

cases:24.84%

controls:23.99%

cases:19.78%

controls:16.93%

cases:12.24%

controls:3.27%

cases:5.89%

controls:0.20%

cases:11.80%

controls:3.00%

cases:21.35%

controls:16.04%

cases:37.24%

controls:33.26%

270

2607

817

8262

215

1840

872

9029

133

355

954

10514

1023

10847

128

326

957

10526

225

1695

829

8871

340

2991

573

6003

Scheduled procedure
ZXD10 [2001311387]

5.9e-01

8.2e-01

1.1e+00

—

2.5e+00

1.8e+00

8.6e-01

cases:9.48%

controls:5.47%

cases:3.86%

controls:1.74%

cases:0.55%

controls:0.18%

—

cases:2.12%

controls:0.18%

cases:6.55%

controls:1.17%

cases:10.73%

controls:4.85%

103

594

984

10275

189

1045

10680

1081

10849

—

1062

10833

124

985

10442

436

815

8558

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

3.8e-02

1.1e-01

1.3e+00

3.8e+00

1.4e+00

2.0e-01

1.5e-01

cases:25.67%

controls:24.94%

cases:22.08%

controls:20.29%

cases:13.34%

controls:3.96%

cases:9.38%

controls:0.24%

cases:13.92%

controls:3.81%

cases:24.38%

controls:20.91%

cases:40.20%

controls:36.66%

279

2711

808

8158

240

2205

847

8664

145

430

942

10439

102

985

10843

151

413

934

10439

257

2209

797

8357

367

3297

546

5697

ABO and Rh group [Type] in Blood
882-1 [3003694]

1.4e-01

2.0e-02

2.4e+00

1.0e+50

3.3e+00

8.1e-01

-1.2e-01

cases:3.96%

controls:3.45%

cases:1.38%

controls:1.35%

cases:1.56%

controls:0.15%

cases:0.92%

controls:0.00%

cases:1.47%

controls:0.06%

cases:2.47%

controls:1.12%

cases:3.40%

controls:3.80%

375

1044

10494

147

1072

10722

1070

10853

1077

10869

1069

10846

118

1028

10448

342

882

8652

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

3.3e-02

9.4e-02

1.3e+00

3.8e+00

1.4e+00

1.9e-01

1.5e-01

cases:25.76%

controls:25.13%

cases:22.08%

controls:20.50%

cases:13.34%

controls:4.07%

cases:9.29%

controls:0.24%

cases:13.82%

controls:3.88%

cases:24.48%

controls:21.09%

cases:40.53%

controls:36.94%

280

2731

807

8138

240

2228

847

8641

145

442

942

10427

101

986

10843

150

421

935

10431

258

2228

796

8338

370

3322

543

5672

General Practice
1 [38004446]

5.9e-02

2.8e-01

1.1e+00

3.5e+00

1.7e+00

3.1e-01

2.2e-01

cases:13.16%

controls:12.49%

cases:6.99%

controls:5.38%

cases:2.67%

controls:0.91%

cases:1.56%

controls:0.05%

cases:4.52%

controls:0.84%

cases:7.78%

controls:5.84%

cases:19.82%

controls:16.56%

143

1358

944

9511

585

1011

10284

1058

10770

1070

10864

1036

10761

617

972

9949

181

1489

732

7505

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

1.3e-01

4.6e-01

3.0e+00

1.0e+50

2.3e+00

9.7e-01

4.2e-01

cases:5.15%

controls:4.57%

cases:2.94%

controls:1.88%

cases:3.96%

controls:0.21%

cases:4.23%

controls:0.00%

cases:2.03%

controls:0.21%

cases:4.08%

controls:1.59%

cases:7.78%

controls:5.26%

497

1031

10372

204

1055

10665

1044

10846

1041

10869

1063

10829

168

1011

10398

473

842

8521

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

-7.3e-02

2.1e-01

2.2e+00

—

2.1e+00

1.1e+00

7.8e-01

cases:3.40%

controls:3.65%

cases:2.02%

controls:1.65%

cases:1.56%

controls:0.18%

—

cases:2.40%

controls:0.29%

cases:4.93%

controls:1.65%

cases:8.65%

controls:4.18%

397

1050

10472

179

1065

10690

1070

10849

—

1059

10821

174

1002

10392

376

834

8618

paracetamol; oral, parenteral, rectal
N02BE01 [21604344]

2.4e-01

3.4e-01

3.1e-01

2.6e+00

1.7e+00

7.0e-01

4.5e-01

cases:34.50%

controls:29.29%

cases:22.08%

controls:16.74%

cases:4.51%

controls:3.36%

cases:2.39%

controls:0.17%

cases:15.85%

controls:3.18%

cases:29.41%

controls:17.21%

cases:46.77%

controls:35.97%

375

3183

712

7686

240

1819

847

9050

365

1038

10504

1061

10850

172

345

913

10507

310

1818

744

8748

427

3235

486

5759

Intravenous general anesthesia
WX404 [2001310807]

5.6e-01

9.9e-01

—

2.4e+00

1.9e+00

8.1e-01

cases:3.68%

controls:2.14%

cases:1.47%

controls:0.55%

—

cases:0.92%

controls:0.08%

cases:2.37%

controls:0.38%

cases:3.07%

controls:1.39%

233

1047

10636

1071

10809

—

1075

10843

1029

10526

125

885

8869

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

1.7e-01

2.2e-02

3.0e+00

1.0e+50

2.0e+00

1.0e+00

4.2e-01

cases:3.86%

controls:3.28%

cases:1.29%

controls:1.26%

cases:2.76%

controls:0.14%

cases:2.76%

controls:0.00%

cases:1.29%

controls:0.18%

cases:3.04%

controls:1.10%

cases:5.70%

controls:3.80%

356

1045

10513

137

1073

10732

1057

10854

1057

10869

1071

10833

116

1022

10450

342

861

8652

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

4.0e-02

1.1e-01

1.2e+00

3.5e+00

1.3e+00

1.6e-01

1.5e-01

cases:27.23%

controls:26.44%

cases:24.93%

controls:22.94%

cases:15.18%

controls:4.91%

cases:9.38%

controls:0.30%

cases:14.84%

controls:4.64%

cases:26.57%

controls:23.58%

cases:42.72%

controls:39.19%

296

2874

791

7995

271

2493

816

8376

165

534

922

10335

102

985

10836

161

504

924

10348

280

2491

774

8075

390

3525

523

5469

One hour or less
ZXE00 [2001311394]

5.5e-01

9.3e-01

9.2e-01

—

2.3e+00

1.4e+00

7.8e-01

cases:8.65%

controls:5.17%

cases:3.59%

controls:1.45%

cases:0.55%

controls:0.22%

—

cases:1.94%

controls:0.19%

cases:5.31%

controls:1.33%

cases:9.20%

controls:4.45%

562

993

10307

158

1048

10711

1081

10845

—

1064

10831

140

998

10426

400

829

8594

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

3.0e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.6e-01

cases:28.89%

controls:28.27%

cases:27.69%

controls:24.80%

cases:16.28%

controls:5.47%

cases:9.75%

controls:0.38%

cases:16.68%

controls:5.23%

cases:29.13%

controls:25.03%

cases:45.45%

controls:41.64%

314

3073

773

7796

301

2696

786

8173

177

595

910

10274

106

981

10828

181

568

904

10284

307

2645

747

7921

415

3745

498

5249

Leukocytes [#/volume] in Blood
26464-8 [3010813]

2.7e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.79%

controls:28.24%

cases:27.60%

controls:24.77%

cases:16.19%

controls:5.45%

cases:9.75%

controls:0.38%

cases:16.68%

controls:5.23%

cases:29.03%

controls:24.99%

cases:45.35%

controls:41.55%

313

3069

774

7800

300

2692

787

8177

176

592

911

10277

106

981

10828

181

568

904

10284

306

2640

748

7926

414

3737

499

5257

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

2.8e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.79%

controls:28.23%

cases:27.60%

controls:24.78%

cases:16.19%

controls:5.46%

cases:9.75%

controls:0.38%

cases:16.68%

controls:5.23%

cases:29.13%

controls:24.99%

cases:45.35%

controls:41.59%

313

3068

774

7801

300

2693

787

8176

176

593

911

10276

106

981

10828

181

568

904

10284

307

2640

747

7926

414

3741

499

5253

Platelets [#/volume] in Blood
26515-7 [3007461]

2.7e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.70%

controls:28.16%

cases:27.60%

controls:24.74%

cases:16.19%

controls:5.47%

cases:9.75%

controls:0.38%

cases:16.68%

controls:5.23%

cases:29.13%

controls:24.93%

cases:45.24%

controls:41.52%

312

3061

775

7808

300

2689

787

8180

176

594

911

10275

106

981

10828

181

568

904

10284

307

2634

747

7932

413

3734

500

5260

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

2.8e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.79%

controls:28.23%

cases:27.60%

controls:24.73%

cases:16.19%

controls:5.46%

cases:9.75%

controls:0.38%

cases:16.59%

controls:5.23%

cases:29.13%

controls:24.98%

cases:45.35%

controls:41.54%

313

3068

774

7801

300

2688

787

8181

176

593

911

10276

106

981

10828

180

568

905

10284

307

2639

747

7927

414

3736

499

5258

MCH [Entitic mass]
28539-5 [3035941]

2.4e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.70%

controls:28.21%

cases:27.51%

controls:24.70%

cases:16.19%

controls:5.46%

cases:9.75%

controls:0.38%

cases:16.59%

controls:5.23%

cases:29.13%

controls:24.93%

cases:45.35%

controls:41.57%

312

3066

775

7803

299

2685

788

8184

176

593

911

10276

106

981

10828

180

568

905

10284

307

2634

747

7932

414

3739

499

5255

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

2.8e-02

1.5e-01

1.2e+00

3.4e+00

1.3e+00

2.1e-01

1.5e-01

cases:28.79%

controls:28.23%

cases:27.60%

controls:24.79%

cases:16.19%

controls:5.47%

cases:9.75%

controls:0.38%

cases:16.59%

controls:5.24%

cases:29.13%

controls:24.97%

cases:45.35%

controls:41.61%

313

3068

774

7801

300

2694

787

8175

176

594

911

10275

106

981

10828

180

569

905

10283

307

2638

747

7928

414

3742

499

5252

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

-4.3e-02

8.0e-02

1.2e+00

3.3e+00

1.3e+00

2.4e-01

1.9e-01

cases:16.93%

controls:17.55%

cases:15.82%

controls:14.79%

cases:9.75%

controls:3.26%

cases:6.53%

controls:0.25%

cases:10.78%

controls:3.31%

cases:18.60%

controls:15.29%

cases:30.56%

controls:26.61%

184

1907

903

8962

172

1607

915

9262

106

354

981

10515

1016

10842

117

359

968

10493

196

1616

858

8950

279

2393

634

6601

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

2.9e-02

1.3e-01

1.1e+00

3.3e+00

1.3e+00

2.6e-01

1.3e-01

cases:20.88%

controls:20.42%

cases:18.40%

controls:16.58%

cases:10.12%

controls:3.63%

cases:6.90%

controls:0.27%

cases:11.34%

controls:3.50%

cases:20.59%

controls:16.61%

cases:34.39%

controls:31.48%

227

2219

860

8650

200

1802

887

9067

110

395

977

10474

1012

10840

123

380

962

10472

217

1755

837

8811

314

2831

599

6163

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

-3.4e-02

1.2e-01

9.6e-01

3.4e+00

1.2e+00

8.7e-02

7.4e-02

cases:17.94%

controls:18.45%

cases:17.48%

controls:15.76%

cases:8.46%

controls:3.41%

cases:6.16%

controls:0.22%

cases:9.86%

controls:3.33%

cases:17.65%

controls:16.42%

cases:28.81%

controls:27.31%

195

2005

892

8864

190

1713

897

9156

371

995

10498

1020

10845

107

361

978

10491

186

1735

868

8831

263

2456

650

6538

General anesthesia, balanced
WX408 [2001310808]

5.2e-01

5.7e-01

—

1.0e+50

2.6e+00

1.7e+00

9.7e-01

cases:4.60%

controls:2.79%

cases:1.29%

controls:0.74%

—

cases:3.96%

controls:0.00%

cases:1.01%

controls:0.07%

cases:2.66%

controls:0.52%

cases:5.59%

controls:2.19%

303

1037

10566

1073

10789

—

1044

10869

1074

10844

1026

10511

197

862

8797

Infection following a procedure, not elsewhere classified
T81.4 [45575538]

5.4e-01

1.1e+00

—

3.3e+00

2.0e+00

-9.1e-02

cases:1.56%

controls:0.92%

cases:0.92%

controls:0.30%

—

cases:1.47%

controls:0.06%

cases:1.71%

controls:0.25%

cases:0.99%

controls:1.08%

100

1070

10769

1077

10836

—

1069

10846

1036

10540

904

8897

Essential (primary) hypertension
I10 [45591453]

-1.7e-01

7.3e-02

3.1e-01

4.2e+00

9.8e-01

2.9e-02

-2.8e-02

cases:14.44%

controls:16.63%

cases:9.38%

controls:8.78%

cases:1.93%

controls:1.43%

cases:4.05%

controls:0.06%

cases:3.23%

controls:1.23%

cases:9.20%

controls:8.96%

cases:21.91%

controls:22.38%

157

1808

930

9061

102

954

985

9915

155

1066

10714

1043

10862

134

1050

10718

947

957

9619

200

2013

713

6981

Laboratory Visit
OMOP4822461 [32036]

4.4e-02

1.4e-01

9.5e-01

3.2e+00

9.2e-01

1.4e-01

9.9e-02

cases:31.74%

controls:30.78%

cases:32.66%

controls:29.61%

cases:21.44%

controls:9.50%

cases:12.60%

controls:0.58%

cases:20.28%

controls:9.21%

cases:33.78%

controls:30.63%

cases:47.75%

controls:45.29%

345

3346

742

7523

355

3218

732

7651

233

1033

854

9836

137

950

10806

220

999

865

9853

356

3236

698

7330

436

4073

477

4921

Removal of sutures
SPAT1153 [2001700254]

4.1e-01

4.8e-01

-1.0e+50

—

3.6e+00

7.7e-01

6.2e-01

cases:7.08%

controls:4.81%

cases:2.12%

controls:1.32%

cases:0.00%

controls:0.10%

—

cases:4.88%

controls:0.14%

cases:2.28%

controls:1.07%

cases:7.56%

controls:4.20%

523

1010

10346

143

1064

10726

1087

10858

—

1032

10837

113

1030

10453

378

844

8616

Normoblasts [#/volume] in Blood
715-3 [3021589]

-9.9e-02

-1.1e-01

8.7e-01

3.2e+00

8.8e-01

9.4e-02

2.3e-01

cases:5.89%

controls:6.46%

cases:4.97%

controls:5.52%

cases:2.48%

controls:1.06%

cases:1.75%

controls:0.07%

cases:2.76%

controls:1.16%

cases:6.07%

controls:5.56%

cases:12.16%

controls:9.91%

702

1023

10167

600

1033

10269

115

1060

10754

1068

10861

126

1055

10726

587

990

9979

111

891

802

8103

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

1.8e-01

3.2e-01

8.4e-01

3.6e+00

5.8e-01

2.4e-01

3.9e-01

cases:16.93%

controls:14.49%

cases:12.14%

controls:9.15%

cases:3.86%

controls:1.70%

cases:3.31%

controls:0.09%

cases:3.23%

controls:1.83%

cases:11.29%

controls:9.10%

cases:26.73%

controls:19.80%

184

1575

903

9294

132

994

955

9875

185

1045

10684

1051

10859

199

1050

10653

119

962

935

9604

244

1781

669

7213

General anaesthesia
WX402 [2001310806]

1.9e-01

7.3e-01

—

1.0e+50

3.0e+00

1.6e+00

5.5e-01

cases:1.93%

controls:1.61%

cases:1.29%

controls:0.63%

—

cases:4.05%

controls:0.00%

cases:1.66%

controls:0.08%

cases:3.51%

controls:0.72%

cases:3.72%

controls:2.19%

175

1066

10694

1073

10801

—

1043

10869

1067

10843

1017

10490

197

879

8797

Ultrasound examination of groin and abdominal wall
JA1AE [2001304364]

2.4e+00

—

1.0e+50

—

2.2e+00

cases:1.01%

controls:0.09%

—

cases:1.10%

controls:0.00%

cases:0.74%

controls:0.00%

—

cases:0.99%

controls:0.11%

1076

10859

—

1075

10869

1077

10852

—

904

8984

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

1.4e-01

1.3e-01

8.5e-01

3.1e+00

2.9e-01

3.4e-01

5.1e-01

cases:10.76%

controls:9.50%

cases:6.62%

controls:5.89%

cases:2.67%

controls:1.16%

cases:2.30%

controls:0.10%

cases:1.75%

controls:1.32%

cases:7.78%

controls:5.66%

cases:19.28%

controls:12.53%

117

1033

970

9836

640

1015

10229

126

1058

10743

1062

10858

143

1066

10709

598

972

9968

176

1127

737

7867

Extensive abdominal CT
JN3BD [2001305556]

6.7e-01

1.8e+00

—

1.0e+50

—

1.8e+00

9.0e-01

cases:1.66%

controls:0.86%

cases:1.01%

controls:0.17%

—

cases:1.38%

controls:0.00%

—

cases:1.14%

controls:0.19%

cases:2.19%

controls:0.90%

1069

10776

1076

10850

—

1072

10869

—

1042

10546

893

8913

Case Management Agency
251B00000X [38004193]

7.2e-03

1.2e-01

5.7e-01

3.2e+00

5.7e-01

1.6e-01

1.0e-01

cases:52.25%

controls:52.07%

cases:48.67%

controls:45.63%

cases:28.79%

controls:18.67%

cases:22.72%

controls:1.22%

cases:28.57%

controls:18.42%

cases:52.28%

controls:48.16%

cases:68.67%

controls:66.47%

568

5660

519

5209

529

4960

558

5909

313

2029

774

8840

247

133

840

10736

310

1999

775

8853

551

5089

503

5477

627

5978

286

3016

Other chronic pain
R52.2 [45568139]

8.5e-01

2.3e+00

—

2.0e+00

1.3e+00

cases:0.64%

controls:0.28%

cases:0.55%

controls:0.06%

—

cases:0.76%

controls:0.10%

cases:0.99%

controls:0.28%

1080

10839

1081

10863

—

1046

10555

904

8969

Atrial fibrillation and flutter
I48 [45596206]

2.6e-01

3.2e-01

6.7e-01

3.3e+00

1.0e+00

2.6e-01

1.9e-01

cases:6.99%

controls:5.50%

cases:3.86%

controls:2.84%

cases:1.38%

controls:0.71%

cases:1.20%

controls:0.05%

cases:1.75%

controls:0.64%

cases:4.17%

controls:3.26%

cases:8.43%

controls:7.09%

598

1011

10271

309

1045

10560

1072

10792

1074

10864

1066

10783

344

1010

10222

638

836

8356

Spinalanesthesia
WX320 [2001310799]

5.1e-01

6.8e-01

—

2.3e+00

1.3e+00

6.3e-01

cases:4.32%

controls:2.65%

cases:1.56%

controls:0.80%

—

cases:0.55%

controls:0.06%

cases:2.94%

controls:0.81%

cases:4.82%

controls:2.62%

288

1040

10581

1070

10782

—

1079

10846

1023

10480

236

869

8758

Internal Medicine
11 [38004456]

1.9e-01

2.3e-01

8.2e-01

3.0e+00

2.8e-01

3.8e-01

2.2e-01

cases:25.39%

controls:22.00%

cases:11.41%

controls:9.28%

cases:3.22%

controls:1.44%

cases:1.29%

controls:0.06%

cases:1.94%

controls:1.47%

cases:12.90%

controls:9.19%

cases:26.73%

controls:22.68%

276

2391

811

8478

124

1009

963

9860

157

1052

10712

1073

10862

159

1064

10693

136

971

918

9595

244

2040

669

6954

Laceration/cut
S18 [2002000983]

2.7e-01

6.1e-01

-1.0e+50

—

2.5e+00

5.7e-01

4.4e-01

cases:8.37%

controls:6.54%

cases:4.51%

controls:2.50%

cases:0.00%

controls:0.30%

—

cases:4.52%

controls:0.37%

cases:3.98%

controls:2.29%

cases:11.72%

controls:7.87%

711

996

10158

272

1038

10597

1087

10836

—

1036

10812

242

1012

10324

107

708

806

8286

Emergency Medicine
93 [38004510]

7.7e-02

4.5e-01

1.6e+00

—

1.3e+00

4.3e-01

3.5e-01

cases:10.58%

controls:9.87%

cases:8.74%

controls:5.73%

cases:3.68%

controls:0.80%

—

cases:2.95%

controls:0.78%

cases:8.25%

controls:5.51%

cases:22.02%

controls:16.58%

115

1073

972

9796

623

992

10246

1047

10782

—

1053

10767

582

967

9984

201

1491

712

7503

cefalexin; oral
J01DB01 [21602870]

1.8e-01

3.8e-01

9.5e-01

—

2.1e+00

3.7e-01

3.4e-01

cases:30.63%

controls:26.93%

cases:12.24%

controls:8.74%

cases:2.30%

controls:0.90%

—

cases:6.73%

controls:0.89%

cases:12.24%

controls:8.77%

cases:34.61%

controls:27.41%

333

2927

754

7942

133

950

954

9919

1062

10771

—

1012

10755

129

927

925

9639

316

2465

597

6529

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

-5.0e-02

3.3e-01

2.1e+00

—

1.5e+00

4.7e-01

2.4e-01

cases:9.11%

controls:9.53%

cases:6.26%

controls:4.59%

cases:3.40%

controls:0.43%

—

cases:3.32%

controls:0.74%

cases:7.02%

controls:4.49%

cases:16.65%

controls:13.53%

1036

988

9833

499

1019

10370

1050

10822

—

1049

10772

474

980

10092

152

1217

761

7777

Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]

1.1e+00

—

1.9e+00

1.1e+00

cases:1.29%

controls:0.44%

—

cases:0.76%

controls:0.11%

cases:1.53%

controls:0.51%

1073

10821

—

1046

10554

899

8948

Supplier / Service Provider
OMOP5117446 [33004]

-7.9e-01

-6.8e-01

2.3e-01

—

1.9e+00

2.4e+00

3.0e+00

cases:13.16%

controls:25.07%

cases:3.86%

controls:7.35%

cases:1.01%

controls:0.81%

—

cases:0.55%

controls:0.08%

cases:4.74%

controls:0.44%

cases:13.91%

controls:0.83%

143

2725

944

8144

799

1045

10070

1076

10781

—

1079

10843

1004

10519

127

786

8919

Bacteria identified in Blood by Culture
600-7 [3023368]

1.9e-01

1.5e-01

1.9e+00

—

1.9e+00

4.5e-01

6.1e-02

cases:3.77%

controls:3.14%

cases:1.84%

controls:1.58%

cases:0.92%

controls:0.14%

—

cases:1.20%

controls:0.18%

cases:2.47%

controls:1.59%

cases:6.13%

controls:5.79%

341

1046

10528

172

1067

10697

1077

10854

—

1072

10833

168

1028

10398

521

857

8473

Short blood count panel - Blood
55429-5 [40758558]

-2.6e-02

1.3e-01

1.2e+00

3.2e+00

6.0e-01

2.6e-01

5.0e-01

cases:3.59%

controls:3.68%

cases:2.48%

controls:2.18%

cases:1.10%

controls:0.35%

cases:1.10%

controls:0.05%

cases:0.92%

controls:0.51%

cases:2.75%

controls:2.13%

cases:8.32%

controls:5.20%

400

1048

10469

237

1060

10632

1075

10831

1075

10864

1075

10797

225

1025

10341

468

837

8526

codeine and paracetamol
N02AJ06 [1123647]

4.1e-01

3.4e-01

9.2e-01

—

1.3e+00

5.0e-01

4.9e-01

cases:16.28%

controls:11.42%

cases:6.72%

controls:4.87%

cases:2.12%

controls:0.86%

—

cases:3.23%

controls:0.86%

cases:7.50%

controls:4.68%

cases:20.26%

controls:13.49%

177

1241

910

9628

529

1014

10340

1064

10776

—

1050

10759

494

975

10072

185

1213

728

7781

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

1.1e-01

4.1e-01

1.3e+00

—

1.1e+00

4.8e-01

3.3e-01

cases:13.25%

controls:12.07%

cases:9.20%

controls:6.31%

cases:3.40%

controls:0.94%

—

cases:2.12%

controls:0.73%

cases:9.49%

controls:6.11%

cases:22.12%

controls:16.90%

144

1312

943

9557

100

686

987

10183

102

1050

10767

—

1062

10773

100

646

954

9920

202

1520

711

7474

Pneumonia, unspecified
J18.9 [45601123]

6.7e-02

-1.7e-01

1.8e+00

—

1.8e+00

5.3e-01

2.9e-01

cases:2.76%

controls:2.59%

cases:0.83%

controls:0.98%

cases:0.64%

controls:0.11%

—

cases:0.92%

controls:0.15%

cases:2.28%

controls:1.35%

cases:5.91%

controls:4.49%

281

1057

10588

106

1078

10763

1080

10857

—

1075

10836

143

1030

10423

404

859

8590

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

2.5e-01

3.2e-01

2.1e+00

1.0e+50

1.5e+00

4.3e-01

3.8e-01

cases:5.61%

controls:4.43%

cases:2.67%

controls:1.96%

cases:1.66%

controls:0.20%

cases:2.30%

controls:0.00%

cases:1.11%

controls:0.26%

cases:2.94%

controls:1.93%

cases:9.53%

controls:6.69%

481

1026

10388

213

1058

10656

1069

10847

1062

10869

1073

10824

204

1023

10362

602

826

8392

Cathetrisation of vein
TPH04 [2001309597]

4.8e-01

5.3e-01

1.9e+00

—

1.3e+00

9.6e-01

7.4e-01

cases:3.50%

controls:2.20%

cases:1.29%

controls:0.76%

cases:0.64%

controls:0.10%

—

cases:0.46%

controls:0.13%

cases:1.80%

controls:0.70%

cases:5.15%

controls:2.51%

239

1049

10630

1073

10786

1080

10858

—

1080

10838

1035

10492

226

866

8768

Obstetrics / Gynecology
16 [38004461]

1.9e-01

4.8e-01

2.3e-01

2.5e+00

1.9e-04

5.2e-01

2.4e-01

cases:15.09%

controls:12.79%

cases:6.99%

controls:4.43%

cases:1.01%

controls:0.81%

cases:0.92%

controls:0.07%

cases:0.74%

controls:0.74%

cases:6.93%

controls:4.24%

cases:13.03%

controls:10.58%

164

1390

923

9479

482

1011

10387

1076

10781

1077

10861

1077

10772

448

981

10118

119

952

794

8042

Left side
ZXA05 [2001311347]

3.9e-01

6.9e-01

1.3e+00

—

2.1e+00

1.4e+00

5.2e-01

cases:4.60%

controls:3.16%

cases:1.47%

controls:0.75%

cases:0.46%

controls:0.13%

—

cases:0.74%

controls:0.09%

cases:2.94%

controls:0.73%

cases:4.82%

controls:2.91%

343

1037

10526

1071

10788

1082

10855

—

1077

10842

1023

10489

262

869

8732

enoxaparin; parenteral
B01AB05 [21600976]

3.4e-01

4.5e-01

5.1e-01

—

2.1e+00

8.2e-01

5.4e-01

cases:6.35%

controls:4.60%

cases:2.21%

controls:1.43%

cases:0.46%

controls:0.28%

—

cases:1.75%

controls:0.22%

cases:2.66%

controls:1.19%

cases:7.67%

controls:4.63%

500

1018

10369

155

1063

10714

1082

10839

—

1066

10828

126

1026

10440

416

843

8578

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

4.4e-02

1.1e-01

5.2e-01

2.8e+00

2.8e-01

4.8e-02

1.5e-01

cases:25.76%

controls:24.93%

cases:21.90%

controls:20.00%

cases:5.98%

controls:3.65%

cases:3.31%

controls:0.20%

cases:4.52%

controls:3.46%

cases:21.06%

controls:20.27%

cases:40.09%

controls:36.62%

280

2710

807

8159

238

2174

849

8695

397

1022

10472

1051

10847

375

1036

10477

222

2142

832

8424

366

3294

547

5700

Varicose veins of lower extremities without ulcer or inflammation
I83.9 [45552859]

4.0e-01

1.5e+00

—

1.8e+00

7.1e-01

cases:1.29%

controls:0.86%

cases:1.10%

controls:0.25%

—

cases:1.61%

controls:0.27%

cases:2.08%

controls:1.03%

1073

10775

1075

10842

—

1037

10537

894

8901

Coloscopy
UJF32 [2001305029]

5.8e-01

8.4e-01

—

1.3e+00

5.7e-01

cases:5.43%

controls:3.13%

cases:2.39%

controls:1.05%

—

cases:3.51%

controls:1.01%

cases:6.68%

controls:3.88%

340

1028

10529

114

1061

10755

—

107

1017

10459

349

852

8645

Pharmacy visit
OMOP4822462 [581458]

4.5e-01

4.8e-01

3.5e-01

1.2e+00

5.8e-01

cases:95.77%

controls:93.52%

cases:89.79%

controls:84.50%

cases:56.03%

controls:47.27%

cases:7.36%

controls:2.32%

cases:61.84%

controls:47.48%

cases:90.99%

controls:85.00%

cases:97.37%

controls:95.40%

1041

10165

704

976

9184

111

1685

609

5138

478

5731

252

1007

10617

671

5153

414

5699

959

8981

1585

889

8580

414

tramadol; oral, parenteral, rectal
N02AX02 [21604298]

5.1e-01

1.7e-01

8.6e-01

—

1.5e+00

6.6e-01

5.0e-01

cases:10.58%

controls:6.61%

cases:3.04%

controls:2.58%

cases:1.01%

controls:0.43%

—

cases:2.40%

controls:0.55%

cases:5.22%

controls:2.75%

cases:10.95%

controls:6.96%

115

718

972

10151

280

1054

10589

1076

10822

—

1059

10792

291

999

10275

100

626

813

8368

Emergency Room and Inpatient Visit
ERIP [262]

3.8e-02

1.8e-01

1.4e+00

—

1.7e+00

4.4e-01

1.6e-01

cases:3.59%

controls:3.46%

cases:2.67%

controls:2.24%

cases:1.10%

controls:0.27%

—

cases:1.84%

controls:0.33%

cases:3.61%

controls:2.36%

cases:8.65%

controls:7.44%

376

1048

10493

244

1058

10625

1075

10840

—

1065

10816

249

1016

10317

669

834

8325

Urgent procedure
ZXD05 [2001311386]

3.5e-01

6.0e-01

—

2.4e+00

2.2e-01

7.0e-01

cases:4.97%

controls:3.55%

cases:1.75%

controls:0.97%

—

cases:1.38%

controls:0.13%

cases:1.23%

controls:0.99%

cases:6.57%

controls:3.38%

386

1033

10483

105

1068

10764

—

1070

10838

105

1041

10461

304

853

8690

12 lead EKG panel
34534-8 [3044889]

4.8e-02

1.6e-01

1.6e+00

1.0e+50

9.6e-01

4.0e-01

2.7e-01

cases:14.17%

controls:13.59%

cases:8.74%

controls:7.54%

cases:4.51%

controls:0.91%

cases:0.55%

controls:0.00%

cases:2.49%

controls:0.97%

cases:10.63%

controls:7.35%

cases:23.55%

controls:18.99%

154

1477

933

9392

820

992

10049

1038

10770

1081

10869

105

1058

10747

112

777

942

9789

215

1708

698

7286

Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]

3.9e-02

5.1e-01

—

2.9e+00

3.9e-01

1.0e-01

cases:1.47%

controls:1.42%

cases:0.92%

controls:0.55%

—

cases:1.20%

controls:0.06%

cases:0.85%

controls:0.58%

cases:2.63%

controls:2.38%

154

1071

10715

1077

10809

—

1072

10845

1045

10505

214

889

8780

pH of Arterial blood
2744-1 [3019977]

-2.7e-02

5.3e-01

—

2.9e+00

3.5e-01

1.7e-01

cases:1.38%

controls:1.42%

cases:0.92%

controls:0.54%

—

cases:1.20%

controls:0.06%

cases:0.85%

controls:0.61%

cases:2.85%

controls:2.41%

154

1072

10715

1077

10810

—

1072

10845

1045

10502

217

887

8777

Base excess in Arterial blood by calculation
1925-7 [3003396]

-2.0e-02

6.4e-01

—

2.9e+00

2.9e-01

1.7e-01

cases:1.38%

controls:1.41%

cases:1.01%

controls:0.53%

—

cases:1.20%

controls:0.06%

cases:0.76%

controls:0.57%

cases:2.85%

controls:2.40%

153

1072

10716

1076

10811

—

1072

10845

1046

10506

216

887

8778

Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]

3.2e-02

5.1e-01

—

2.9e+00

3.9e-01

1.0e-01

cases:1.47%

controls:1.43%

cases:0.92%

controls:0.55%

—

cases:1.20%

controls:0.06%

cases:0.85%

controls:0.58%

cases:2.63%

controls:2.38%

155

1071

10714

1077

10809

—

1072

10845

1045

10505

214

889

8780

Thorax X-ray examination
GD1AA [2001303617]

3.7e-01

2.0e-01

1.4e+00

—

7.9e-01

8.5e-01

6.5e-01

cases:9.48%

controls:6.76%

cases:3.68%

controls:3.03%

cases:1.20%

controls:0.29%

—

cases:0.65%

controls:0.29%

cases:5.98%

controls:2.65%

cases:14.90%

controls:8.39%

103

735

984

10134

329

1047

10540

1074

10837

—

1078

10820

280

991

10286

136

755

777

8239

Inpatient Visit
IP [9201]

1.8e-01

7.8e-02

6.6e-01

—

2.0e+00

8.2e-01

4.1e-01

cases:6.53%

controls:5.53%

cases:2.12%

controls:1.96%

cases:0.46%

controls:0.24%

—

cases:1.84%

controls:0.25%

cases:4.55%

controls:2.05%

cases:8.76%

controls:5.99%

601

1016

10268

213

1064

10656

1082

10843

—

1065

10825

217

1006

10349

539

833

8455

Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]

-1.9e-01

8.0e-01

—

2.8e+00

1.5e-01

1.3e-01

cases:0.92%

controls:1.11%

cases:0.92%

controls:0.41%

—

cases:1.01%

controls:0.06%

cases:0.57%

controls:0.49%

cases:2.19%

controls:1.92%

121

1077

10748

1077

10824

—

1074

10845

1048

10514

173

893

8821

Oxygen saturation in Arterial blood
2708-6 [3016502]

4.8e-02

8.1e-01

—

2.8e+00

4.0e-01

3.0e-01

cases:1.20%

controls:1.14%

cases:1.01%

controls:0.45%

—

cases:1.01%

controls:0.06%

cases:0.76%

controls:0.51%

cases:2.74%

controls:2.05%

124

1074

10745

1076

10820

—

1074

10845

1046

10512

184

888

8810

Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]

2.1e-01

1.4e-02

—

2.7e+00

5.1e-01

1.6e-01

cases:1.56%

controls:1.27%

cases:0.64%

controls:0.63%

—

cases:1.11%

controls:0.07%

cases:1.23%

controls:0.75%

cases:3.07%

controls:2.61%

138

1070

10731

1080

10800

—

1073

10844

1041

10487

235

885

8759

Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]

3.1e-02

—

2.7e+00

9.0e-01

1.6e-01

cases:0.92%

controls:0.89%

—

cases:0.83%

controls:0.06%

cases:0.85%

controls:0.35%

cases:1.97%

controls:1.68%

1077

10772

—

1076

10846

1045

10529

151

895

8843

Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]

4.0e-01

—

2.7e+00

—

7.0e-01

1.9e-01

cases:2.48%

controls:1.68%

—

cases:0.83%

controls:0.06%

—

cases:0.95%

controls:0.47%

cases:2.63%

controls:2.19%

183

1060

10686

—

1078

10863

—

1044

10516

197

889

8797

Laparoscopy
JAH01 [2001304475]

4.1e-01

—

1.0e+50

—

2.7e+00

1.4e+00

cases:0.55%

controls:0.37%

—

cases:1.38%

controls:0.00%

—

cases:0.95%

controls:0.07%

cases:0.88%

controls:0.21%

1081

10829

—

1072

10869

—

1044

10559

905

8975

Bacteria identified in Isolate by Culture
43409-2 [3042936]

1.7e-01

4.2e-01

—

2.7e+00

9.0e-01

4.0e-01

cases:1.93%

controls:1.63%

cases:1.29%

controls:0.85%

—

cases:1.29%

controls:0.09%

cases:1.61%

controls:0.66%

cases:3.40%

controls:2.31%

177

1066

10692

1073

10777

—

1071

10842

1037

10496

208

882

8786

Heart failure, unspecified
I50.9 [45576879]

-3.0e-01

9.7e-02

5.1e-01

2.6e+00

7.7e-01

1.6e-01

-1.9e-01

cases:1.20%

controls:1.60%

cases:1.10%

controls:1.00%

cases:0.46%

controls:0.28%

cases:0.64%

controls:0.05%

cases:0.55%

controls:0.26%

cases:1.33%

controls:1.14%

cases:2.63%

controls:3.17%

174

1074

10695

109

1075

10760

1082

10839

1080

10864

1079

10824

120

1040

10446

285

889

8709

Urology
34 [38004474]

3.5e-01

6.7e-01

1.2e+00

1.0e+50

9.8e-01

8.0e-01

2.8e-01

cases:7.18%

controls:5.14%

cases:4.69%

controls:2.47%

cases:1.47%

controls:0.46%

cases:1.01%

controls:0.00%

cases:1.29%

controls:0.49%

cases:5.60%

controls:2.60%

cases:8.43%

controls:6.54%

559

1009

10310

268

1036

10601

1071

10819

1076

10869

1071

10799

275

995

10291

588

836

8406

Office Visit
OMOP4822458 [581477]

9.8e-02

6.0e-01

1.0e+00

—

1.6e+00

3.3e-01

4.0e-01

cases:8.28%

controls:7.56%

cases:3.77%

controls:2.12%

cases:0.83%

controls:0.30%

—

cases:1.11%

controls:0.22%

cases:3.23%

controls:2.34%

cases:10.41%

controls:7.23%

822

997

10047

230

1046

10639

1078

10836

—

1073

10828

247

1020

10319

650

818

8344

Gas panel - Arterial blood
24336-0 [3019060]

1.9e-01

9.2e-01

—

2.6e+00

—

2.5e-01

cases:1.01%

controls:0.84%

cases:0.74%

controls:0.29%

—

cases:0.74%

controls:0.06%

—

cases:1.64%

controls:1.29%

1076

10778

1079

10837

—

1077

10846

—

116

898

8878

Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]

3.4e-02

1.1e+00

—

2.6e+00

—

2.2e-01

cases:0.83%

controls:0.80%

cases:1.01%

controls:0.34%

—

cases:0.74%

controls:0.06%

—

cases:1.86%

controls:1.50%

1078

10782

1076

10832

—

1077

10846

—

135

896

8859

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

1.7e-01

2.1e-01

9.4e-01

—

1.5e+00

5.1e-01

5.2e-01

cases:7.64%

controls:6.54%

cases:4.42%

controls:3.62%

cases:1.47%

controls:0.58%

—

cases:2.76%

controls:0.61%

cases:5.69%

controls:3.50%

cases:15.12%

controls:9.56%

711

1004

10158

394

1039

10475

1071

10806

—

1055

10786

370

994

10196

138

860

775

8134

Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]

1.2e+00

9.9e-01

—

1.3e+00

cases:2.48%

controls:0.77%

cases:0.64%

controls:0.24%

—

cases:0.76%

controls:0.21%

cases:2.41%

controls:0.66%

1060

10785

1080

10843

—

1046

10544

891

8935

Suture or treatment of traumatic wound
SPAT1149 [2001700250]

-2.9e-02

4.5e-01

-1.0e+50

—

2.5e+00

5.6e-01

2.5e-01

cases:1.29%

controls:1.32%

cases:0.74%

controls:0.47%

cases:0.00%

controls:0.05%

—

cases:0.55%

controls:0.05%

cases:0.66%

controls:0.38%

cases:2.19%

controls:1.71%

144

1073

10725

1079

10818

1087

10864

—

1079

10847

1047

10526

154

893

8840

Sacro-iliac joint MRI examination with high intensity magnet
NA6BG [2001307059]

2.5e+00

—

cases:0.55%

controls:0.05%

—

1081

10864

—

metronidazole; oral, rectal
P01AB01 [21604857]

2.2e-01

2.7e-01

1.1e+00

—

2.5e+00

3.2e-01

2.9e-01

cases:7.54%

controls:6.16%

cases:2.39%

controls:1.83%

cases:0.46%

controls:0.16%

—

cases:1.20%

controls:0.10%

cases:2.09%

controls:1.52%

cases:7.45%

controls:5.67%

669

1005

10200

199

1061

10670

1082

10852

—

1072

10841

161

1032

10405

510

845

8484

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

8.0e-01

—

1.6e+00

6.8e-01

8.8e-01

cases:6.62%

controls:3.10%

cases:2.02%

controls:0.92%

—

cases:0.55%

controls:0.11%

cases:1.99%

controls:1.02%

cases:8.11%

controls:3.52%

337

1015

10532

100

1065

10769

—

1079

10840

108

1033

10458

317

839

8677

nimesulide; oral
M01AX17 [21604007]

3.5e-01

6.3e-01

—

2.5e+00

6.6e-01

6.9e-02

cases:2.85%

controls:2.03%

cases:1.01%

controls:0.54%

—

cases:0.65%

controls:0.06%

cases:1.04%

controls:0.54%

cases:2.08%

controls:1.95%

221

1056

10648

1076

10810

—

1078

10846

1043

10509

175

894

8819

levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]

1.8e-01

5.7e-01

—

2.5e+00

2.5e-02

3.2e-01

cases:2.67%

controls:2.24%

cases:1.20%

controls:0.68%

—

cases:0.65%

controls:0.06%

cases:0.85%

controls:0.83%

cases:3.83%

controls:2.81%

243

1058

10626

1074

10795

—

1078

10846

1045

10478

253

878

8741

Localized enlarged lymph nodes
R59.0 [45534459]

7.4e-01

—

2.4e+00

—

cases:0.46%

controls:0.22%

—

cases:0.76%

controls:0.07%

—

1082

10845

—

1046

10559

—

Resection of long saphenous vein
PHD76 [2001309493]

8.4e-01

—

2.4e+00

8.1e-01

cases:0.55%

controls:0.24%

—

cases:0.76%

controls:0.07%

cases:0.55%

controls:0.24%

1081

10843

—

1046

10559

908

8972

ciprofloxacin; oral, parenteral
J01MA02 [21603009]

2.4e-01

3.1e-01

1.1e+00

—

1.8e+00

6.6e-01

1.7e-01

cases:6.90%

controls:5.50%

cases:2.58%

controls:1.90%

cases:0.64%

controls:0.22%

—

cases:1.01%

controls:0.18%

cases:3.61%

controls:1.89%

cases:7.67%

controls:6.57%

598

1012

10271

206

1059

10663

1080

10845

—

1074

10833

200

1016

10366

591

843

8403

Constipation, unspecified
K59.09 [2000502926]

1.0e+00

9.2e-01

—

1.5e+00

9.6e-01

cases:1.10%

controls:0.40%

cases:0.46%

controls:0.18%

—

cases:0.85%

controls:0.20%

cases:1.86%

controls:0.72%

1075

10826

1082

10849

—

1045

10545

896

8929

Teaching
WZC30 [2001310891]

2.7e-01

8.8e-01

2.4e+00

1.0e+50

—

8.8e-01

5.0e-01

cases:1.84%

controls:1.42%

cases:1.47%

controls:0.62%

cases:1.01%

controls:0.09%

cases:0.46%

controls:0.00%

—

cases:1.52%

controls:0.63%

cases:3.07%

controls:1.88%

154

1067

10715

1071

10802

1076

10859

1082

10869

—

1038

10499

169

885

8825

Abdominal pain localized other
D06 [2002000305]

8.1e-01

2.4e+00

—

7.9e-01

6.5e-01

cases:1.38%

controls:0.62%

cases:1.75%

controls:0.17%

—

cases:0.66%

controls:0.30%

cases:1.64%

controls:0.87%

1072

10802

1068

10851

—

1047

10534

898

8916

Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]

-1.5e-01

5.9e-01

2.3e+00

—

1.5e+00

6.1e-01

4.9e-01

cases:1.38%

controls:1.60%

cases:1.29%

controls:0.72%

cases:0.92%

controls:0.09%

—

cases:0.55%

controls:0.12%

cases:1.23%

controls:0.67%

cases:2.74%

controls:1.69%

174

1072

10695

1073

10791

1077

10859

—

1079

10839

1041

10495

152

888

8842

Pelvic, hip and femur extensive MRI examination with high intensity magnet
NE1CG [2001307805]

—

2.3e+00

—

cases:0.77%

controls:0.08%

—

906

8987

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]

5.7e-01

—

2.2e+00

7.5e-01

cases:1.20%

controls:0.68%

—

cases:1.23%

controls:0.13%

cases:0.99%

controls:0.47%

1074

10795

—

1041

10552

904

8952

amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]

4.2e-01

8.3e-02

1.0e+00

—

1.8e+00

3.3e-01

3.7e-01

cases:9.20%

controls:6.22%

cases:2.48%

controls:2.29%

cases:0.46%

controls:0.17%

—

cases:1.11%

controls:0.18%

cases:3.23%

controls:2.35%

cases:11.06%

controls:7.89%

100

676

987

10193

249

1060

10620

1082

10851

—

1073

10832

248

1020

10318

101

710

812

8284

Nonallergic asthma
J45.1 [45557625]

7.2e-01

8.0e-01

—

1.3e+00

8.5e-01

cases:1.93%

controls:0.95%

cases:0.92%

controls:0.41%

—

cases:1.33%

controls:0.35%

cases:2.30%

controls:1.00%

103

1066

10766

1077

10824

—

1040

10529

892

8904

Exposure to unspecified factor
X59 [45756412]

5.9e-01

8.4e-01

—

2.2e+00

6.7e-01

4.5e-01

cases:3.13%

controls:1.76%

cases:1.29%

controls:0.56%

—

cases:0.65%

controls:0.07%

cases:1.23%

controls:0.63%

cases:3.07%

controls:1.98%

191

1053

10678

1073

10808

—

1078

10844

1041

10499

178

885

8816

Vascular Surgery
77 [38004496]

5.5e-01

6.6e-01

1.1e+00

—

1.1e+00

9.1e-01

7.1e-01

cases:4.23%

controls:2.49%

cases:2.02%

controls:1.06%

cases:0.55%

controls:0.18%

—

cases:0.46%

controls:0.16%

cases:2.37%

controls:0.97%

cases:6.02%

controls:3.07%

271

1041

10598

115

1065

10754

1081

10849

—

1080

10835

102

1029

10464

276

858

8718

oxycodone; oral, parenteral
N02AA05 [21604260]

7.7e-01

6.5e-01

9.9e-01

—

1.1e+00

8.2e-01

5.8e-01

cases:2.58%

controls:1.21%

cases:1.47%

controls:0.77%

cases:0.74%

controls:0.28%

—

cases:0.74%

controls:0.26%

cases:2.18%

controls:0.97%

cases:4.71%

controls:2.69%

132

1059

10737

1071

10785

1079

10839

—

1077

10824

103

1031

10463

242

870

8752

Persistent somatoform pain disorder
F45.4 [45605498]

—

2.2e+00

—

cases:0.77%

controls:0.09%

—

906

8986

Follow-up examination after surgery for other conditions
Z09.0 [45576131]

5.7e-01

1.6e+00

—

2.1e+00

4.1e-01

cases:1.10%

controls:0.63%

cases:0.46%

controls:0.09%

—

cases:1.04%

controls:0.12%

cases:0.77%

controls:0.51%

1075

10801

1082

10859

—

1043

10553

906

8948

Pelvic and perineal pain
R10.2 [45548947]

-1.0e+50

—

2.1e+00

cases:0.00%

controls:0.14%

—

cases:0.66%

controls:0.08%

1087

10854

—

907

8987

Resection of other vein
PHD99 [2001309496]

7.2e-01

—

2.1e+00

8.5e-01

cases:0.74%

controls:0.36%

—

cases:0.76%

controls:0.09%

cases:0.88%

controls:0.38%

1079

10830

—

1046

10556

905

8960

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

3.7e-01

4.3e-01

5.8e-01

—

2.1e+00

5.8e-01

3.8e-01

cases:8.56%

controls:6.08%

cases:2.48%

controls:1.63%

cases:0.46%

controls:0.26%

—

cases:1.57%

controls:0.20%

cases:2.75%

controls:1.56%

cases:6.13%

controls:4.29%

661

994

10208

177

1060

10692

1082

10841

—

1068

10830

165

1025

10401

386

857

8608

Gas panel - Venous blood
24339-4 [3000991]

-1.1e-02

—

2.1e+00

4.9e-01

3.6e-01

cases:0.83%

controls:0.84%

—

cases:0.65%

controls:0.08%

cases:0.66%

controls:0.41%

cases:2.19%

controls:1.55%

1078

10778

—

1078

10843

1047

10523

139

893

8855

Sedation and analgesia
WX002 [2001310758]

1.3e-01

2.0e-01

—

1.3e+00

7.7e-01

cases:2.21%

controls:1.95%

cases:0.83%

controls:0.68%

—

cases:1.99%

controls:0.57%

cases:4.16%

controls:1.98%

212

1063

10657

1078

10795

—

1033

10506

178

875

8816

Benign neoplasm: Rectum
D12.8 [45595734]

4.8e-01

—

2.0e+00

9.1e-01

cases:0.46%

controls:0.29%

—

cases:0.57%

controls:0.08%

cases:0.77%

controls:0.31%

1082

10838

—

1048

10558

906

8966

denosumab; parenteral
M05BX04 [21604169]

1.0e+00

9.8e-01

—

8.7e-01

3.1e-01

cases:1.66%

controls:0.60%

cases:1.66%

controls:0.63%

—

cases:1.61%

controls:0.68%

cases:1.53%

controls:1.13%

1069

10804

1069

10801

—

1037

10494

102

899

8892

Pain in joint
M25.5 [45586941]

5.6e-01

3.5e-01

—

7.9e-01

6.6e-01

cases:5.15%

controls:3.01%

cases:1.84%

controls:1.30%

—

cases:2.75%

controls:1.27%

cases:7.67%

controls:4.12%

327

1031

10542

141

1067

10728

—

134

1025

10432

371

843

8623

Other minor surgical procedure in gynaecology
TLW99 [2001306821]

—

2.0e+00

—

cases:0.66%

controls:0.09%

—

907

8986

Treatment of chronic ulcer or burn
SPAT1148 [2001700249]

4.3e-01

9.1e-01

—

2.0e+00

5.0e-01

6.0e-01

cases:2.21%

controls:1.44%

cases:1.29%

controls:0.52%

—

cases:1.01%

controls:0.14%

cases:1.14%

controls:0.69%

cases:3.94%

controls:2.20%

157

1063

10712

1073

10812

—

1074

10837

1042

10493

198

877

8796

Gastroenterology
10 [38004455]

6.0e-01

5.9e-01

7.0e-01

—

8.2e-01

7.5e-01

6.3e-01

cases:6.62%

controls:3.74%

cases:2.94%

controls:1.65%

cases:0.55%

controls:0.28%

—

cases:0.65%

controls:0.29%

cases:3.32%

controls:1.60%

cases:8.87%

controls:4.94%

407

1015

10462

179

1055

10690

1081

10839

—

1078

10821

169

1019

10397

444

832

8550

Infiltration anesthesia
WX110 [2001310767]

7.7e-02

3.0e-01

2.4e-01

—

9.1e-01

7.1e-01

3.3e-01

cases:14.35%

controls:13.43%

cases:7.08%

controls:5.34%

cases:0.92%

controls:0.73%

—

cases:2.30%

controls:0.94%

cases:11.01%

controls:5.72%

cases:21.36%

controls:16.37%

156

1460

931

9409

580

1010

10289

1077

10790

—

102

1060

10750

116

604

938

9962

195

1472

718

7522

Other therap proced/minor surg NEC
-59 [2002000130]

1.9e+00

—

9.6e-01

cases:0.83%

controls:0.12%

—

cases:0.55%

controls:0.21%

1078

10856

—

908

8975

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

7.5e-02

4.2e-01

1.2e+00

—

7.5e-01

3.7e-01

cases:13.62%

controls:12.75%

cases:9.94%

controls:6.77%

cases:2.94%

controls:0.95%

—

cases:1.57%

controls:0.75%

cases:9.01%

controls:6.40%

cases:22.89%

controls:17.08%

148

1386

939

9483

108

736

979

10133

103

1055

10766

—

1068

10771

676

959

9890

209

1536

704

7458

Localized swelling, mass and lump, unspecified
R22.9 [45577788]

1.7e-02

1.9e+00

—

1.3e+00

3.9e-01

cases:0.55%

controls:0.54%

cases:1.29%

controls:0.19%

—

cases:0.57%

controls:0.15%

cases:1.20%

controls:0.82%

1081

10810

1073

10848

—

1048

10550

902

8920

EKG study
11524-6 [3013512]

1.1e-01

4.2e-02

1.9e+00

1.0e+50

7.9e-01

5.4e-03

1.1e-01

cases:6.90%

controls:6.22%

cases:3.68%

controls:3.53%

cases:2.85%

controls:0.45%

cases:0.46%

controls:0.00%

cases:0.83%

controls:0.38%

cases:3.42%

controls:3.40%

cases:9.31%

controls:8.42%

676

1012

10193

384

1047

10485

1056

10820

1082

10869

1076

10811

359

1018

10207

757

828

8237

Flexible laryngoscopy
UDQ12 [2001301827]

3.6e-01

—

1.9e+00

6.1e-01

cases:0.64%

controls:0.45%

—

cases:0.66%

controls:0.10%

cases:1.10%

controls:0.60%

1080

10820

—

1047

10555

903

8940

Body CT examination
JN4AD [2001310897]

4.6e-01

4.4e-01

1.9e+00

—

-5.6e-02

1.4e-01

cases:1.10%

controls:0.70%

cases:0.64%

controls:0.41%

cases:0.64%

controls:0.10%

—

cases:0.47%

controls:0.50%

cases:1.31%

controls:1.15%

1075

10793

1080

10824

1080

10858

—

1049

10513

103

901

8891

etanercept; parenteral
L04AB01 [21603908]

1.9e+00

—

cases:0.64%

controls:0.10%

—

1080

10858

—

oxycodone and naloxone; oral
N02AA55 [21604265]

2.8e-01

2.5e-01

—

1.8e+00

7.2e-01

4.0e-01

cases:2.12%

controls:1.61%

cases:0.92%

controls:0.72%

—

cases:0.92%

controls:0.15%

cases:1.42%

controls:0.70%

cases:3.83%

controls:2.61%

175

1064

10694

1077

10791

—

1075

10836

1039

10492

235

878

8759

Other specified special examinations
Z01.8 [45581003]

7.8e-01

-5.2e-01

—

1.9e+00

1.0e+00

1.6e-01

cases:4.60%

controls:2.15%

cases:0.46%

controls:0.77%

—

cases:0.55%

controls:0.08%

cases:1.99%

controls:0.71%

cases:3.29%

controls:2.82%

234

1037

10635

1082

10785

—

1079

10843

1033

10491

254

883

8740

olodaterol and tiotropium bromide
R03AL06 [1588644]

—

1.8e+00

—

cases:1.10%

controls:0.18%

—

903

8978

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

9.1e-02

3.2e-01

1.2e+00

—

7.3e-01

5.8e-01

3.4e-01

cases:5.70%

controls:5.24%

cases:3.68%

controls:2.70%

cases:1.29%

controls:0.38%

—

cases:0.65%

controls:0.31%

cases:4.74%

controls:2.71%

cases:10.62%

controls:7.82%

569

1025

10300

293

1047

10576

1073

10828

—

1078

10818

286

1004

10280

703

816

8291

Day surgery
ZXD20 [2001311388]

5.4e-01

7.0e-01

—

1.0e+50

—

1.8e+00

7.0e-01

cases:1.75%

controls:1.03%

cases:0.55%

controls:0.28%

—

cases:2.02%

controls:0.00%

—

cases:1.61%

controls:0.27%

cases:2.08%

controls:1.05%

112

1068

10757

1081

10839

—

1065

10869

—

1037

10538

894

8900

Exploration of joint of shoulder or upper arm, arthroscopic
NBA30 [2001307269]

1.8e+00

—

cases:0.92%

controls:0.16%

—

1077

10852

—

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

1.6e-01

2.3e-01

3.4e-01

—

1.3e+00

4.3e-01

4.9e-01

cases:8.46%

controls:7.29%

cases:4.88%

controls:3.93%

cases:0.83%

controls:0.59%

—

cases:2.12%

controls:0.60%

cases:5.79%

controls:3.83%

cases:14.79%

controls:9.58%

792

995

10077

427

1034

10442

1078

10805

—

1062

10787

405

993

10161

135

862

778

8132

Operation for humeroscapular osteochondritis, arthroscopic
NBF25 [2001307294]

1.8e+00

—

1.7e+00

cases:0.64%

controls:0.11%

—

cases:0.66%

controls:0.12%

1080

10857

—

907

8983

Anxiety disorder/anxiety state
P74 [2002000868]

—

1.8e+00

—

cases:1.20%

controls:0.21%

—

902

8975

Postmenopausal osteoporosis with pathological fracture
M80.0 [45572553]

1.7e+00

1.8e+00

—

9.9e-01

cases:0.74%

controls:0.13%

cases:0.46%

controls:0.07%

—

cases:0.66%

controls:0.24%

1079

10855

1082

10861

—

907

8972

Microorganisms panel - Urine sediment
58435-9 [40761536]

5.2e-01

9.1e-01

—

6.3e-01

8.1e-01

cases:2.30%

controls:1.38%

cases:1.75%

controls:0.71%

—

cases:1.23%

controls:0.66%

cases:3.29%

controls:1.49%

150

1062

10719

1068

10792

—

1041

10496

134

883

8860

ibandronic acid; oral, parenteral
M05BA06 [21604154]

—

1.7e+00

—

cases:0.99%

controls:0.18%

—

904

8978

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

1.1e-01

4.0e-01

1.7e+00

—

7.0e-01

5.3e-01

2.8e-01

cases:6.53%

controls:5.87%

cases:4.23%

controls:2.87%

cases:1.75%

controls:0.32%

—

cases:0.74%

controls:0.37%

cases:4.65%

controls:2.80%

cases:11.72%

controls:9.12%

638

1016

10231

312

1041

10557

1068

10834

—

1077

10812

296

1005

10270

107

820

806

8174

Hand and fingers X-ray examination
ND2AA [2001307607]

8.7e-01

—

1.7e+00

9.0e-01

cases:1.56%

controls:0.66%

—

cases:0.76%

controls:0.14%

cases:1.86%

controls:0.77%

1070

10797

—

1046

10551

896

8925

Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]

1.7e+00

—

cases:0.74%

controls:0.14%

—

1079

10854

—

doxycycline; oral, parenteral
J01AA02 [21602800]

4.2e-01

4.1e-01

5.0e-01

—

-2.8e-01

4.3e-01

4.2e-01

cases:25.11%

controls:18.09%

cases:8.46%

controls:5.81%

cases:0.83%

controls:0.51%

—

cases:0.46%

controls:0.61%

cases:7.87%

controls:5.25%

cases:22.23%

controls:15.80%

273

1966

814

8903

631

995

10238

1078

10814

—

1080

10786

555

971

10011

203

1421

710

7573

Pain in limb
M79.6 [45587063]

3.9e-02

6.1e-01

—

9.2e-01

6.3e-01

4.3e-01

cases:5.24%

controls:5.05%

cases:3.96%

controls:2.20%

—

cases:0.46%

controls:0.18%

cases:3.70%

controls:2.01%

cases:10.95%

controls:7.40%

549

1030

10320

239

1044

10630

—

1080

10832

212

1015

10354

100

666

813

8328

FEV1/FVC
19926-5 [3011505]

6.3e-01

6.0e-01

—

1.0e+00

1.6e+00

cases:3.04%

controls:1.65%

cases:1.10%

controls:0.61%

—

cases:1.23%

controls:0.44%

cases:4.16%

controls:0.83%

179

1054

10690

1075

10803

—

1041

10519

875

8919

Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]

6.3e-01

6.0e-01

—

1.0e+00

1.6e+00

cases:3.04%

controls:1.65%

cases:1.10%

controls:0.61%

—

cases:1.23%

controls:0.44%

cases:4.16%

controls:0.83%

179

1054

10690

1075

10803

—

1041

10519

875

8919

FEV1
20150-9 [3024653]

6.3e-01

6.0e-01

—

1.0e+00

1.6e+00

cases:3.04%

controls:1.65%

cases:1.10%

controls:0.61%

—

cases:1.23%

controls:0.44%

cases:4.16%

controls:0.83%

179

1054

10690

1075

10803

—

1041

10519

875

8919

Mycobacterium sp identified in Specimen
40699-1 [3042631]

1.6e+00

—

cases:0.83%

controls:0.17%

—

1078

10851

—

Monitoring vital functions without anesthesia
WX000 [2001310756]

—

1.6e+00

—

cases:0.99%

controls:0.20%

—

904

8976

Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]

7.5e-01

8.5e-01

-1.0e+50

—

1.6e+00

9.1e-01

cases:1.20%

controls:0.57%

cases:0.64%

controls:0.28%

cases:0.00%

controls:0.05%

—

cases:1.23%

controls:0.26%

cases:1.75%

controls:0.71%

1074

10807

1080

10839

1087

10864

—

1041

10539

897

8930

Exploration of knee joint, arthroscopic
NGA30 [2001308091]

1.6e+00

—

1.2e+00

cases:1.01%

controls:0.21%

—

cases:0.55%

controls:0.17%

1076

10846

—

908

8979

FVC percent change Respiratory system
69982-7 [42868471]

6.2e-01

—

1.2e+00

1.6e+00

cases:2.58%

controls:1.41%

cases:0.92%

controls:0.50%

—

cases:1.14%

controls:0.35%

cases:3.40%

controls:0.73%

153

1059

10716

1077

10815

—

1042

10529

882

8928

FEV1/FVC --post bronchodilation
69970-2 [42868459]

6.2e-01

—

1.2e+00

1.6e+00

cases:2.58%

controls:1.41%

cases:0.92%

controls:0.50%

—

cases:1.14%

controls:0.35%

cases:3.40%

controls:0.73%

153

1059

10716

1077

10815

—

1042

10529

882

8928

FEV1 percent change
69983-5 [42868472]

6.2e-01

—

1.2e+00

1.6e+00

cases:2.58%

controls:1.41%

cases:0.92%

controls:0.50%

—

cases:1.14%

controls:0.35%

cases:3.40%

controls:0.73%

153

1059

10716

1077

10815

—

1042

10529

882

8928

FEV1 --post bronchodilation
20155-8 [3023550]

6.2e-01

—

1.2e+00

1.6e+00

cases:2.58%

controls:1.41%

cases:0.92%

controls:0.50%

—

cases:1.14%

controls:0.35%

cases:3.40%

controls:0.73%

153

1059

10716

1077

10815

—

1042

10529

882

8928

Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]

6.2e-01

—

1.2e+00

1.6e+00

cases:2.58%

controls:1.41%

cases:0.92%

controls:0.50%

—

cases:1.14%

controls:0.35%

cases:3.40%

controls:0.73%

153

1059

10716

1077

10815

—

1042

10529

882

8928

Thoracal epidural anesthesia
WX302 [2001310795]

3.8e-01

—

1.6e+00

cases:0.64%

controls:0.44%

—

cases:1.10%

controls:0.23%

1080

10821

—

903

8973

Orthopedic Surgery
20 [38004465]

4.3e-01

3.3e-01

5.5e-01

—

3.8e-02

5.4e-01

5.6e-01

cases:19.50%

controls:13.56%

cases:7.36%

controls:5.42%

cases:1.66%

controls:0.97%

—

cases:1.01%

controls:0.98%

cases:9.01%

controls:5.44%

cases:24.10%

controls:15.30%

212

1474

875

9395

589

1007

10280

105

1069

10764

—

106

1074

10746

575

959

9991

220

1376

693

7618

Puncture of maxillary antrum
TDM10 [2001301819]

1.5e+00

—

cases:1.01%

controls:0.22%

—

1076

10845

—

Pelvis X-ray examination
NE1AA [2001307792]

3.9e-01

6.2e-01

-1.0e+50

—

1.5e+00

8.7e-01

cases:0.92%

controls:0.63%

cases:0.46%

controls:0.25%

cases:0.00%

controls:0.06%

—

cases:0.85%

controls:0.19%

cases:1.86%

controls:0.79%

1077

10801

1082

10842

1087

10863

—

1045

10546

896

8923

Colonoscopy
SPAT1131 [2001700232]

—

1.5e+00

—

cases:0.99%

controls:0.22%

—

904

8974

azithromycin; oral, parenteral
J01FA10 [21602978]

4.1e-01

4.8e-01

9.5e-01

—

6.4e-01

4.4e-01

cases:11.32%

controls:7.84%

cases:3.31%

controls:2.07%

cases:0.74%

controls:0.29%

—

cases:3.98%

controls:2.14%

cases:10.19%

controls:6.82%

123

852

964

10017

225

1051

10644

1079

10838

—

226

1012

10340

613

820

8381

Telehealth
OMOP5556618 [722455]

1.6e-01

2.9e-01

7.0e-01

—

7.8e-01

3.0e-01

2.2e-01

cases:22.08%

controls:19.39%

cases:11.04%

controls:8.49%

cases:2.76%

controls:1.39%

—

cases:2.86%

controls:1.33%

cases:10.63%

controls:8.11%

cases:23.88%

controls:20.10%

240

2108

847

8761

120

923

967

9946

151

1057

10718

—

144

1054

10708

112

857

942

9709

218

1808

695

7186

Lump/swelling localized
S04 [2002000969]

5.8e-01

1.4e+00

—

7.7e-01

7.1e-01

cases:1.47%

controls:0.83%

cases:1.01%

controls:0.24%

—

cases:0.57%

controls:0.27%

cases:1.75%

controls:0.87%

1071

10779

1076

10843

—

1048

10538

897

8916

Other blockage of nerve
WX290 [2001310792]

-1.3e-02

2.3e-01

8.7e-01

—

1.4e+00

2.5e-01

1.0e-01

cases:5.80%

controls:5.87%

cases:2.48%

controls:1.99%

cases:0.46%

controls:0.19%

—

cases:1.01%

controls:0.25%

cases:2.56%

controls:2.02%

cases:8.11%

controls:7.39%

638

1024

10231

216

1060

10653

1082

10848

—

1074

10825

213

1027

10353

665

839

8329

Plastic And Reconstructive Surgery
24 [38004467]

4.0e-01

7.8e-01

1.5e+00

1.0e+50

—

8.3e-01

5.8e-01

cases:3.59%

controls:2.44%

cases:1.93%

controls:0.89%

cases:0.83%

controls:0.19%

cases:0.55%

controls:0.00%

—

cases:1.99%

controls:0.88%

cases:4.82%

controls:2.77%

265

1048

10604

1066

10772

1078

10848

1081

10869

—

1033

10473

249

869

8745

Albumin [Presence] in Urine by Test strip
50949-7 [3029937]

3.4e-01

5.1e-01

1.4e+00

—

1.1e+00

3.8e-01

2.9e-01

cases:6.35%

controls:4.60%

cases:4.60%

controls:2.81%

cases:1.47%

controls:0.37%

—

cases:1.01%

controls:0.35%

cases:3.98%

controls:2.75%

cases:10.19%

controls:7.83%

500

1018

10369

305

1037

10564

1071

10829

—

1074

10814

291

1012

10275

704

820

8290

Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]

4.1e-01

1.4e+00

—

6.7e-01

2.6e-01

cases:1.38%

controls:0.92%

cases:1.20%

controls:0.30%

—

cases:0.57%

controls:0.29%

cases:1.42%

controls:1.10%

100

1072

10769

1074

10836

—

1048

10535

900

8895

Hip joint ultrasound examination
NF1AE [2001307895]

—

1.4e+00

—

cases:1.10%

controls:0.28%

—

903

8969

tizanidine; oral
M03BX02 [21604116]

3.1e-01

4.4e-01

5.8e-01

—

1.9e-04

5.2e-01

5.5e-01

cases:15.00%

controls:11.43%

cases:5.43%

controls:3.58%

cases:1.01%

controls:0.57%

—

cases:0.55%

controls:0.55%

cases:5.88%

controls:3.59%

cases:17.52%

controls:10.96%

163

1242

924

9627

389

1028

10480

1076

10807

—

1079

10792

379

992

10187

160

986

753

8008

trimethoprim; oral, parenteral
J01EA01 [21602931]

1.2e-01

4.2e-01

5.1e-01

—

1.4e+00

1.9e-01

-1.6e-02

cases:6.44%

controls:5.78%

cases:3.40%

controls:2.25%

cases:0.55%

controls:0.33%

—

cases:1.01%

controls:0.26%

cases:2.75%

controls:2.28%

cases:6.90%

controls:7.00%

628

1017

10241

245

1050

10624

1081

10833

—

1074

10824

241

1025

10325

630

850

8364

prednisolone
A07EA01 [21600653]

3.5e-01

4.9e-01

5.4e-01

—

-1.8e-01

3.3e-01

5.1e-01

cases:12.33%

controls:9.02%

cases:7.36%

controls:4.63%

cases:1.66%

controls:0.98%

—

cases:0.83%

controls:1.00%

cases:6.55%

controls:4.79%

cases:17.42%

controls:11.27%

134

980

953

9889

503

1007

10366

106

1069

10763

—

108

1076

10744

506

985

10060

159

1014

754

7980

Other extensive ultrasound examination of artery
PG1DE [2001309713]

5.3e-01

—

1.3e+00

cases:0.74%

controls:0.43%

—

cases:1.31%

controls:0.34%

1079

10822

—

901

8963

prednisolone; oral, parenteral
H02AB06 [21602734]

3.5e-01

5.0e-01

5.6e-01

—

-1.8e-01

3.4e-01

5.1e-01

cases:12.24%

controls:8.98%

cases:7.36%

controls:4.62%

cases:1.66%

controls:0.96%

—

cases:0.83%

controls:1.00%

cases:6.55%

controls:4.76%

cases:17.31%

controls:11.21%

133

976

954

9893

502

1007

10367

104

1069

10765

—

108

1076

10744

503

985

10063

158

1008

755

7986

salbutamol; inhalant
R03AC02 [21603256]

1.9e-01

4.5e-01

5.5e-01

—

3.7e-02

4.2e-01

4.8e-01

cases:14.54%

controls:12.32%

cases:9.66%

controls:6.39%

cases:2.12%

controls:1.23%

—

cases:1.29%

controls:1.24%

cases:9.49%

controls:6.45%

cases:21.36%

controls:14.44%

158

1339

929

9530

105

695

982

10174

134

1064

10735

—

135

1071

10717

100

681

954

9885

195

1299

718

7695

Abdominal pain/cramps general
D01 [2002000300]

6.4e-01

1.3e+00

—

-1.0e+50

5.7e-01

7.2e-01

cases:1.66%

controls:0.88%

cases:1.01%

controls:0.27%

—

cases:0.00%

controls:0.06%

cases:0.57%

controls:0.32%

cases:2.85%

controls:1.41%

1069

10773

1076

10840

—

1085

10845

1048

10532

127

887

8867

Headache
R51.80 [2000503603]

4.7e-01

1.3e+00

—

-1.0e+50

1.0e+00

3.9e-01

cases:2.30%

controls:1.44%

cases:1.29%

controls:0.34%

—

cases:0.00%

controls:0.05%

cases:1.04%

controls:0.39%

cases:2.74%

controls:1.88%

157

1062

10712

1073

10832

—

1085

10847

1043

10525

169

888

8825

formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]

—

1.3e+00

—

cases:1.20%

controls:0.32%

—

902

8965

Hand Surgery
40 [38004480]

6.9e-01

-2.1e-01

—

6.4e-01

6.3e-01

cases:4.32%

controls:2.23%

cases:0.64%

controls:0.79%

—

cases:1.42%

controls:0.76%

cases:4.71%

controls:2.56%

242

1040

10627

1080

10783

—

1039

10486

230

870

8764

pregabalin; oral
N02BF02 [955152]

1.7e-01

2.9e-01

1.4e-02

—

4.6e-01

7.6e-01

5.6e-01

cases:4.14%

controls:3.51%

cases:2.21%

controls:1.67%

cases:0.64%

controls:0.63%

—

cases:0.83%

controls:0.53%

cases:3.13%

controls:1.50%

cases:6.35%

controls:3.72%

381

1042

10488

181

1063

10688

1080

10800

—

1076

10795

158

1021

10408

335

855

8659

Radical radiotherapy
WF002 [2001310701]

—

-1.0e+50

—

1.3e+00

—

cases:0.00%

controls:0.06%

—

cases:1.20%

controls:0.33%

—

1087

10862

—

902

8964

Abdominal CT examination
JN3AD [2001305554]

2.5e-01

1.2e+00

2.3e+00

—

2.3e+00

1.2e+00

4.5e-01

cases:1.01%

controls:0.79%

cases:1.10%

controls:0.34%

cases:0.46%

controls:0.05%

—

cases:0.46%

controls:0.05%

cases:1.33%

controls:0.39%

cases:2.08%

controls:1.33%

1076

10783

1075

10832

1082

10864

—

1080

10847

1040

10525

120

894

8874

Osteoporosis
L95 [2002000714]

1.2e+00

—

9.2e-01

5.6e-01

cases:1.20%

controls:0.36%

cases:0.74%

controls:0.23%

—

cases:0.57%

controls:0.23%

cases:0.99%

controls:0.57%

1074

10830

1079

10844

—

1048

10542

904

8943

Bacteria identified in Urine by Culture
630-4 [3026008]

-1.4e-02

5.2e-01

1.2e+00

—

3.0e-01

3.1e-01

6.9e-02

cases:4.97%

controls:5.03%

cases:3.96%

controls:2.38%

cases:1.10%

controls:0.33%

—

cases:0.46%

controls:0.34%

cases:3.51%

controls:2.60%

cases:8.43%

controls:7.92%

547

1033

10322

259

1044

10610

1075

10833

—

1080

10815

275

1017

10291

712

836

8282

Uroflowmetry
44856007 [4261340]

1.3e-01

5.7e-01

—

1.2e+00

5.2e-01

cases:2.39%

controls:2.11%

cases:1.20%

controls:0.68%

—

cases:1.80%

controls:0.55%

cases:3.29%

controls:1.98%

229

1061

10640

1074

10795

—

1035

10508

178

883

8816

Acromioplastia, arthroscopic
NBG15 [2001307302]

1.2e+00

—

7.7e-01

cases:1.66%

controls:0.51%

—

cases:1.10%

controls:0.51%

1069

10814

—

903

8948

Physical Medicine And Rehabilitation
25 [38004468]

3.9e-01

5.0e-01

7.3e-01

—

1.1e+00

6.4e-01

5.0e-01

cases:8.10%

controls:5.60%

cases:3.13%

controls:1.91%

cases:0.55%

controls:0.27%

—

cases:0.83%

controls:0.27%

cases:3.51%

controls:1.87%

cases:9.97%

controls:6.30%

609

999

10260

208

1053

10661

1081

10840

—

1076

10823

198

1017

10368

567

822

8427

Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]

1.1e+00

—

1.0e+00

cases:1.56%

controls:0.51%

—

cases:1.20%

controls:0.44%

1070

10814

—

902

8954

Medical examin/health eval partial
-31 [2002000102]

1.1e+00

-1.0e+50

—

3.7e-01

cases:1.29%

controls:0.42%

cases:0.00%

controls:0.15%

—

cases:0.66%

controls:0.46%

1073

10823

1087

10853

—

907

8953

Abdominal ultrasound examination
JN3AE [2001305555]

1.7e-01

7.9e-01

—

6.3e-01

1.1e+00

cases:1.38%

controls:1.17%

cases:0.83%

controls:0.38%

—

cases:0.85%

controls:0.45%

cases:3.40%

controls:1.13%

127

1072

10742

1078

10828

—

1045

10518

102

882

8892

Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]

7.1e-01

1.1e+00

—

7.2e-01

4.2e-01

cases:2.48%

controls:1.23%

cases:1.29%

controls:0.43%

—

cases:1.04%

controls:0.51%

cases:2.52%

controls:1.67%

134

1060

10735

1073

10822

—

1043

10512

150

890

8844

Primary total prosthetic replacement of hip joint not using cement
NFB30 [2001307921]

2.8e-01

—

1.1e+00

cases:0.83%

controls:0.63%

—

cases:0.57%

controls:0.20%

cases:1.64%

controls:0.56%

1078

10801

—

1048

10545

898

8944

Urinary tract infection, site not specified
N39.0 [45548665]

7.2e-02

1.1e+00

—

3.2e-01

1.4e-01

cases:1.47%

controls:1.37%

cases:1.75%

controls:0.61%

—

cases:1.04%

controls:0.76%

cases:2.85%

controls:2.48%

149

1071

10720

1068

10803

—

1043

10486

223

887

8771

Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]

8.7e-01

1.2e+00

—

7.0e-01

1.1e+00

cases:1.56%

controls:0.66%

cases:0.83%

controls:0.24%

—

cases:0.47%

controls:0.24%

cases:2.08%

controls:0.73%

1070

10797

1078

10843

—

1049

10541

894

8928

Stomatognathic treatment, basic
SHA02 [2001310406]

—

1.2e+00

—

-1.0e+50

—

1.0e+00

—

cases:0.46%

controls:0.14%

—

cases:0.00%

controls:0.05%

—

cases:1.75%

controls:0.63%

—

1082

10854

—

1085

10847

—

897

8937

Abdominal pain epigastric
D02 [2002000301]

8.4e-01

—

1.0e+00

cases:0.83%

controls:0.36%

—

cases:1.53%

controls:0.56%

1078

10830

—

899

8944

Ventricular premature depolarization
I49.3 [45538386]

4.9e-01

—

6.6e-01

1.0e+00

cases:1.10%

controls:0.68%

—

cases:0.47%

controls:0.25%

cases:1.86%

controls:0.68%

1075

10795

—

1049

10540

896

8933

celecoxib; oral
M01AH01 [21603992]

5.5e-01

6.4e-01

—

9.9e-01

5.3e-01

cases:3.31%

controls:1.94%

cases:1.20%

controls:0.63%

—

cases:1.52%

controls:0.57%

cases:3.07%

controls:1.82%

211

1051

10658

1074

10800

—

1038

10506

164

885

8830

celecoxib
L01XX33 [21603805]

5.5e-01

6.4e-01

—

9.9e-01

5.3e-01

cases:3.31%

controls:1.94%

cases:1.20%

controls:0.63%

—

cases:1.52%

controls:0.57%

cases:3.07%

controls:1.82%

211

1051

10658

1074

10800

—

1038

10506

164

885

8830

tolfenamic acid; oral, rectal
M01AG02 [21603988]

5.5e-01

—

2.1e+00

—

-1.0e+50

1.1e+00

9.9e-01

cases:2.30%

controls:1.33%

—

cases:0.46%

controls:0.06%

—

cases:0.00%

controls:0.06%

cases:1.04%

controls:0.35%

cases:1.97%

controls:0.74%

145

1062

10724

—

1082

10863

—

1085

10845

1043

10529

895

8927

Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]

2.0e-01

5.8e-01

1.2e+00

—

9.8e-01

3.0e-01

cases:4.23%

controls:3.51%

cases:1.84%

controls:1.04%

cases:0.46%

controls:0.14%

—

cases:2.47%

controls:0.94%

cases:4.16%

controls:3.11%

381

1041

10488

113

1067

10756

1082

10854

—

1028

10467

280

875

8714

Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]

-7.0e-02

-1.7e-01

—

9.5e-01

9.7e-01

cases:1.29%

controls:1.38%

cases:0.46%

controls:0.54%

—

cases:1.23%

controls:0.48%

cases:4.16%

controls:1.61%

150

1073

10719

1082

10810

—

1041

10515

145

875

8849

saccharomyces boulardii; oral
A07FA02 [21600670]

-1.3e-01

—

9.7e-01

cases:0.55%

controls:0.63%

—

cases:1.86%

controls:0.71%

1081

10801

—

896

8930

Functional dyspepsia
K30 [45591584]

2.7e-01

8.7e-01

-1.0e+50

—

9.7e-01

cases:1.29%

controls:0.98%

cases:0.46%

controls:0.19%

cases:0.00%

controls:0.05%

—

cases:2.52%

controls:0.97%

107

1073

10762

1082

10848

1087

10864

—

890

8907

Hand/finger symptom/complaint
L12 [2002000636]

3.6e-01

-1.3e-01

—

9.5e-01

9.7e-01

cases:2.12%

controls:1.49%

cases:0.46%

controls:0.52%

—

cases:1.14%

controls:0.44%

cases:4.93%

controls:1.92%

162

1064

10707

1082

10812

—

1042

10519

173

868

8821

More than three and less than five hours
ZXE20 [2001311408]

6.4e-01

—

1.0e+50

—

7.3e-01

9.6e-01

cases:2.39%

controls:1.28%

—

cases:0.46%

controls:0.00%

—

cases:0.66%

controls:0.32%

cases:2.41%

controls:0.93%

139

1061

10730

—

1082

10869

—

1047

10532

891

8910

fluticasone; nasal
R01AD08 [21605050]

3.7e-01

5.7e-01

7.2e-01

—

4.3e-01

3.4e-01

cases:10.49%

controls:7.50%

cases:5.52%

controls:3.20%

cases:0.92%

controls:0.45%

—

cases:4.55%

controls:3.01%

cases:10.30%

controls:7.53%

114

815

973

10054

348

1027

10521

1077

10820

—

318

1006

10248

677

819

8317

fluticasone furoate; nasal
R01AD12 [21605053]

3.7e-01

5.7e-01

7.2e-01

—

4.3e-01

3.4e-01

cases:10.49%

controls:7.50%

cases:5.52%

controls:3.20%

cases:0.92%

controls:0.45%

—

cases:4.55%

controls:3.01%

cases:10.30%

controls:7.53%

114

815

973

10054

348

1027

10521

1077

10820

—

318

1006

10248

677

819

8317

Thoracic and Cardiac Surgery
OMOP4822009 [45756830]

2.8e-01

5.9e-01

—

6.6e-01

9.3e-01

cases:1.29%

controls:0.98%

cases:0.64%

controls:0.36%

—

cases:0.47%

controls:0.25%

cases:1.97%

controls:0.79%

106

1073

10763

1080

10830

—

1049

10540

895

8923

Acute maxillary sinusitis
J01.0 [45601112]

3.0e-01

2.2e-01

—

-1.0e+50

9.2e-01

4.1e-01

cases:3.31%

controls:2.47%

cases:1.29%

controls:1.04%

—

cases:0.00%

controls:0.06%

cases:1.90%

controls:0.77%

cases:4.60%

controls:3.09%

269

1051

10600

113

1073

10756

—

1085

10846

1034

10485

278

871

8716

Therapeutic discussion
SPAT1240 [2001700341]

-1.5e-01

8.2e-01

—

9.9e-01

9.2e-01

cases:0.74%

controls:0.86%

cases:0.64%

controls:0.29%

—

cases:0.76%

controls:0.28%

cases:2.41%

controls:0.98%

1079

10776

1080

10838

—

1046

10536

891

8906

Foot and toes X-ray examination
NH3AA [2001308267]

7.6e-01

—

1.1e+00

9.1e-01

cases:1.56%

controls:0.74%

—

cases:0.76%

controls:0.26%

cases:2.19%

controls:0.89%

1070

10789

—

1046

10539

893

8914

Hallux valgus (acquired)
M20.1 [45606152]

9.0e-01

9.2e-01

—

1.1e+00

7.1e-01

cases:1.75%

controls:0.72%

cases:0.55%

controls:0.22%

—

cases:0.66%

controls:0.23%

cases:1.64%

controls:0.81%

1068

10791

1081

10845

—

1047

10542

898

8921

Primary arthrosis of other joints
M19.0 [45601353]

6.8e-01

1.1e-01

—

2.5e-01

9.0e-01

cases:1.84%

controls:0.94%

cases:0.46%

controls:0.41%

—

cases:0.57%

controls:0.44%

cases:2.63%

controls:1.09%

102

1067

10767

1082

10824

—

1048

10519

889

8896

Ankle symptom/complaint
L16 [2002000640]

3.3e-01

1.3e-01

—

-1.0e+50

5.2e-01

8.9e-01

cases:1.29%

controls:0.93%

cases:0.46%

controls:0.40%

—

cases:0.00%

controls:0.06%

cases:0.47%

controls:0.28%

cases:2.63%

controls:1.10%

101

1073

10768

1082

10825

—

1085

10845

1049

10536

889

8895

Venous insufficiency (chronic)(peripheral)
I87.2 [45552867]

5.6e-01

9.6e-01

—

9.3e-01

8.8e-01

cases:2.02%

controls:1.17%

cases:1.20%

controls:0.46%

—

cases:1.23%

controls:0.49%

cases:3.50%

controls:1.48%

127

1065

10742

1074

10819

—

1041

10514

133

881

8861

cetirizine; oral
R06AE07 [21603497]

3.6e-01

2.2e-01

6.1e-01

—

5.1e-01

5.2e-01

3.4e-01

cases:10.21%

controls:7.35%

cases:4.32%

controls:3.51%

cases:1.20%

controls:0.65%

—

cases:0.92%

controls:0.55%

cases:5.31%

controls:3.24%

cases:9.53%

controls:6.96%

111

799

976

10070

381

1040

10488

1074

10798

—

1075

10792

342

998

10224

626

826

8368

amoxicillin; oral, parenteral
J01CA04 [21602823]

2.4e-01

4.5e-01

-4.2e-02

—

5.2e-02

3.7e-01

4.3e-01

cases:24.66%

controls:20.49%

cases:9.48%

controls:6.28%

cases:0.64%

controls:0.67%

—

cases:0.55%

controls:0.53%

cases:8.44%

controls:6.01%

cases:27.38%

controls:19.77%

268

2227

819

8642

103

683

984

10186

1080

10796

—

1079

10795

635

965

9931

250

1778

663

7216

dexamethasone and antiinfectives
S02CA06 [21605178]

4.6e-01

6.1e-01

—

-1.0e+50

—

8.6e-01

cases:1.29%

controls:0.82%

cases:0.64%

controls:0.35%

—

cases:0.00%

controls:0.05%

—

cases:2.30%

controls:0.99%

1073

10780

1080

10831

—

1085

10847

—

892

8905

Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]

4.9e-01

—

-1.0e+50

—

4.2e-01

8.6e-01

cases:1.29%

controls:0.79%

—

cases:0.00%

controls:0.06%

—

cases:0.47%

controls:0.31%

cases:2.30%

controls:0.99%

1073

10783

—

1087

10863

—

1049

10533

892

8905

Pain localized to upper abdomen
R10.1 [45568111]

3.0e-01

6.3e-01

—

2.7e-01

8.5e-01

cases:1.93%

controls:1.44%

cases:1.10%

controls:0.59%

—

cases:0.57%

controls:0.44%

cases:4.71%

controls:2.07%

157

1066

10712

1075

10805

—

1048

10520

186

870

8808

fluconazole; oral, parenteral
J02AC01 [21603080]

3.9e-01

3.1e-01

—

1.3e+00

3.1e-01

4.5e-01

cases:8.46%

controls:5.88%

cases:2.67%

controls:1.97%

—

cases:0.74%

controls:0.21%

cases:2.66%

controls:1.96%

cases:8.00%

controls:5.26%

639

995

10230

214

1058

10655

—

1077

10829

207

1026

10359

473

840

8521

Check up of cardiac pacemaker
XFP20 [2001303367]

5.1e-01

1.5e-01

—

5.3e-01

8.4e-01

cases:1.66%

controls:1.00%

cases:0.74%

controls:0.63%

—

cases:1.04%

controls:0.62%

cases:2.74%

controls:1.20%

109

1069

10760

1079

10800

—

1043

10501

108

888

8886

Pain, unspecified
R52.9 [45544151]

-3.1e-01

—

1.1e+00

8.3e-01

cases:0.55%

controls:0.75%

—

cases:0.76%

controls:0.27%

cases:2.52%

controls:1.11%

1081

10787

—

1046

10538

100

890

8894

esomeprazole; oral, parenteral
A02BC05 [21600100]

3.6e-01

2.8e-01

5.0e-01

—

5.4e-01

1.4e-01

4.7e-01

cases:10.86%

controls:7.84%

cases:5.34%

controls:4.07%

cases:1.47%

controls:0.90%

—

cases:1.47%

controls:0.87%

cases:4.46%

controls:3.91%

cases:12.49%

controls:8.18%

118

852

969

10017

442

1029

10427

1071

10771

—

1069

10758

413

1007

10153

114

736

799

8258

Laboratory test
15220000 [4034850]

3.1e-01

3.2e-01

—

1.2e+00

8.3e-01

-5.7e-02

cases:2.39%

controls:1.76%

cases:1.20%

controls:0.87%

—

cases:0.46%

controls:0.14%

cases:2.18%

controls:0.97%

cases:3.18%

controls:3.36%

191

1061

10678

1074

10774

—

1080

10837

102

1031

10464

302

884

8692

Cardiac arrhythmia, unspecified
I49.9 [45581778]

8.1e-01

1.0e+00

—

6.7e-01

7.0e-01

cases:2.30%

controls:1.04%

cases:0.92%

controls:0.34%

—

cases:0.66%

controls:0.34%

cases:2.63%

controls:1.32%

113

1062

10756

1077

10832

—

1047

10530

119

889

8875

Other specified chronic obstructive pulmonary disease
J44.8 [45586673]

6.4e-01

6.2e-01

1.1e+00

—

8.0e-01

5.4e-01

cases:3.04%

controls:1.63%

cases:2.02%

controls:1.09%

cases:0.83%

controls:0.29%

—

cases:2.47%

controls:1.13%

cases:3.72%

controls:2.21%

177

1054

10692

119

1065

10750

1078

10838

—

119

1028

10447

199

879

8795

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]

-2.5e-01

—

2.3e+00

1.0e+50

—

6.0e-01

8.0e-01

cases:0.92%

controls:1.18%

—

cases:0.46%

controls:0.05%

cases:0.64%

controls:0.00%

—

cases:0.95%

controls:0.52%

cases:3.18%

controls:1.46%

128

1077

10741

—

1082

10864

1080

10869

—

1044

10511

131

884

8863

diazepam; oral, parenteral, rectal
N05BA01 [21604566]

7.7e-01

6.7e-01

9.2e-01

—

8.2e-01

2.3e-01

1.2e-01

cases:4.97%

controls:2.36%

cases:2.48%

controls:1.29%

cases:0.55%

controls:0.22%

—

cases:0.65%

controls:0.29%

cases:1.52%

controls:1.21%

cases:2.85%

controls:2.55%

257

1033

10612

140

1060

10729

1081

10845

—

1078

10821

128

1038

10438

229

887

8765

Shortness of breath/dyspnoea
R02 [2002000883]

1.9e-01

7.0e-01

—

-1.0e+50

5.8e-01

7.7e-01

cases:1.56%

controls:1.30%

cases:0.83%

controls:0.41%

—

cases:0.00%

controls:0.10%

cases:0.76%

controls:0.43%

cases:4.05%

controls:1.92%

141

1070

10728

1078

10824

—

1085

10841

1046

10521

173

876

8821

pantoprazole; oral, parenteral
A02BC02 [21600097]

2.3e-01

1.9e-01

4.8e-01

—

2.8e-01

3.6e-01

4.0e-01

cases:18.12%

controls:14.90%

cases:10.40%

controls:8.76%

cases:3.40%

controls:2.14%

—

cases:2.58%

controls:1.95%

cases:12.71%

controls:9.20%

cases:24.97%

controls:18.31%

197

1620

890

9249

113

952

974

9917

233

1050

10636

—

212

1057

10640

134

972

920

9594

228

1647

685

7347

Other primary coxarthrosis
M16.1 [45591741]

1.9e-01

7.1e-01

—

7.8e-01

7.3e-01

cases:2.30%

controls:1.90%

cases:1.47%

controls:0.73%

—

cases:1.61%

controls:0.75%

cases:4.05%

controls:1.99%

207

1062

10662

1071

10790

—

1037

10487

179

876

8815

calcium (different salts in combination); oral
A12AA20 [21600872]

2.6e-01

3.0e-01

3.6e-01

-1.0e+50

1.3e-01

3.6e-01

cases:11.22%

controls:8.90%

cases:9.94%

controls:7.55%

cases:2.76%

controls:1.95%

cases:0.00%

controls:0.05%

cases:2.67%

controls:2.35%

cases:10.91%

controls:7.86%

cases:15.33%

controls:11.17%

122

967

965

9902

108

821

979

10048

212

1057

10657

1087

10864

255

1056

10597

115

831

939

9735

140

1005

773

7989

cromoglicic acid
S01GX01 [21605085]

7.2e-01

5.4e-01

—

3.2e-01

4.7e-01

cases:4.51%

controls:2.24%

cases:1.47%

controls:0.86%

—

cases:1.23%

controls:0.90%

cases:3.72%

controls:2.37%

244

1038

10625

1071

10775

—

1041

10471

213

879

8781

Respiratory and circulatory monitoring
WX700 [2001310817]

3.7e-01

6.0e-01

—

5.7e-01

6.9e-01

cases:2.76%

controls:1.92%

cases:0.92%

controls:0.51%

—

cases:0.85%

controls:0.48%

cases:3.50%

controls:1.79%

209

1057

10660

1077

10814

—

1045

10515

161

881

8833

Bacteria [Presence] in Urine
87829-8 [36304419]

1.3e-01

3.7e-01

9.9e-01

—

1.1e+00

6.8e-01

3.1e-01

cases:4.05%

controls:3.56%

cases:2.67%

controls:1.85%

cases:0.64%

controls:0.24%

—

cases:0.55%

controls:0.19%

cases:3.70%

controls:1.90%

cases:7.45%

controls:5.57%

387

1043

10482

201

1058

10668

1080

10843

—

1079

10831

201

1015

10365

501

845

8493

tiotropium bromide; inhalant
R03BB04 [21603296]

6.8e-01

6.0e-01

7.2e-01

—

7.0e-02

4.9e-01

5.5e-01

cases:3.68%

controls:1.90%

cases:2.58%

controls:1.44%

cases:0.92%

controls:0.45%

—

cases:0.55%

controls:0.52%

cases:2.37%

controls:1.47%

cases:3.94%

controls:2.31%

206

1047

10663

156

1059

10713

1077

10820

—

1079

10796

155

1029

10411

208

877

8786

long-acting sulfonamides - combinations
J01ED20 [21602959]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

cough suppressants and expectorants
R05FB02 [21603442]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

hydroxyethylpromethazine, combinations
R06AD55 [21603490]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

diphenhydramine, combinations
R06AA52 [21603454]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

dextromethorphan, combinations; oral
N07XX59 [43534835]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

cough suppressants and mucolytics
R05FB01 [21603441]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

short-acting sulfonamides - combinations
J01EB20 [21602943]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

intermediate-acting sulfonamides - combinations
J01EC20 [21602948]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

promethazine, combinations
R06AD52 [21603489]

6.7e-01

—

-1.0e+50

—

-1.0e+50

6.7e-01

5.4e-01

cases:3.59%

controls:1.87%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.34%

cases:1.97%

controls:1.16%

203

1048

10666

—

1087

10863

—

1085

10847

1047

10530

104

895

8890

salbutamol; oral, parenteral
R03CC02 [21603312]

6.7e-01

—

-1.0e+50

—

-1.0e+50

5.6e-01

5.4e-01

cases:3.86%

controls:2.01%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.38%

cases:2.19%

controls:1.29%

219

1045

10650

—

1087

10862

—

1085

10847

1047

10526

116

893

8878

Chest pain, unspecified
R07.4 [45558450]

2.9e-01

3.3e-01

—

7.4e-01

6.7e-01

cases:5.52%

controls:4.20%

cases:1.66%

controls:1.20%

—

cases:2.18%

controls:1.05%

cases:8.32%

controls:4.46%

456

1027

10413

130

1069

10739

—

111

1031

10455

401

837

8593

tamsulosin; oral
G04CA02 [21602669]

2.9e-01

3.9e-01

6.2e-01

—

6.7e-01

4.7e-01

6.6e-01

cases:5.61%

controls:4.27%

cases:4.32%

controls:2.97%

cases:1.47%

controls:0.80%

—

cases:1.57%

controls:0.81%

cases:4.93%

controls:3.13%

cases:10.19%

controls:5.53%

464

1026

10405

323

1040

10546

1071

10782

—

1068

10764

331

1002

10235

497

820

8497

phenylpropanolamine, combinations; oral
R01BA51 [21603212]

6.6e-01

—

-1.0e+50

—

-1.0e+50

6.4e-01

5.3e-01

cases:3.68%

controls:1.94%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.35%

cases:1.97%

controls:1.17%

211

1047

10658

—

1087

10862

—

1085

10847

1047

10529

105

895

8889

dextromethorphan; oral
R05DA09 [21603404]

6.6e-01

-2.5e-01

-1.0e+50

—

-1.0e+50

6.2e-01

4.1e-01

cases:3.68%

controls:1.94%

cases:0.46%

controls:0.59%

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.36%

cases:1.97%

controls:1.31%

211

1047

10658

1082

10805

1087

10863

—

1085

10847

1047

10528

118

895

8876

opium derivatives and expectorants
R05FA02 [21603439]

6.6e-01

—

-1.0e+50

—

-1.0e+50

6.4e-01

5.3e-01

cases:3.68%

controls:1.94%

—

cases:0.00%

controls:0.06%

—

cases:0.00%

controls:0.05%

cases:0.66%

controls:0.35%

cases:1.97%

controls:1.17%

211

1047

10658

—

1087

10862

—

1085

10847

1047

10529

105

895

8889

antibiotics in combination with other drugs
S01AA20 [21603571]

1.5e-01

2.6e-01

9.2e-01

—

9.9e-01

6.5e-01

1.6e-01

cases:9.02%

controls:7.88%

cases:3.31%

controls:2.57%

cases:0.64%

controls:0.26%

—

cases:0.65%

controls:0.24%

cases:4.17%

controls:2.21%

cases:9.86%

controls:8.53%

857

989

10012

279

1051

10590

1080

10841

—

1078

10826

234

1010

10332

767

823

8227

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

7.6e-02

4.8e-01

9.9e-01

—

9.6e-01

6.5e-01

2.7e-01

cases:4.05%

controls:3.76%

cases:3.13%

controls:1.96%

cases:0.74%

controls:0.28%

—

cases:0.55%

controls:0.21%

cases:3.80%

controls:2.02%

cases:7.67%

controls:5.95%

409

1043

10460

213

1053

10656

1079

10839

—

1079

10829

213

1014

10353

535

843

8459

Physiotherapy
R4110 [2001310233]

3.0e-02

-1.2e-01

—

9.6e-01

3.1e-01

6.4e-01

cases:4.23%

controls:4.11%

cases:1.29%

controls:1.44%

—

cases:0.55%

controls:0.21%

cases:1.90%

controls:1.40%

cases:6.90%

controls:3.76%

447

1041

10422

157

1073

10712

—

1079

10829

148

1034

10418

338

850

8656

omeprazole; oral, parenteral
A02BC01 [21600096]

3.2e-01

3.3e-01

7.3e-01

—

3.6e-01

4.4e-01

6.3e-01

cases:5.70%

controls:4.21%

cases:2.58%

controls:1.87%

cases:0.64%

controls:0.31%

—

cases:0.55%

controls:0.39%

cases:2.94%

controls:1.92%

cases:6.57%

controls:3.60%

458

1025

10411

203

1059

10666

1080

10835

—

1079

10810

203

1023

10363

324

853

8670

Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]

2.8e-01

4.0e-01

—

8.1e-01

6.3e-01

cases:3.04%

controls:2.32%

cases:1.29%

controls:0.86%

—

cases:1.90%

controls:0.85%

cases:5.48%

controls:2.99%

252

1054

10617

1073

10775

—

1034

10476

269

863

8725

Rheumatology
66 [38004491]

4.9e-01

6.1e-01

4.9e-01

—

7.3e-01

5.3e-01

6.2e-01

cases:4.60%

controls:2.86%

cases:3.13%

controls:1.72%

cases:0.64%

controls:0.40%

—

cases:0.65%

controls:0.31%

cases:2.94%

controls:1.75%

cases:5.48%

controls:3.02%

311

1037

10558

187

1053

10682

1080

10826

—

1078

10818

185

1023

10381

272

863

8722

Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]

1.2e-01

2.8e-01

—

5.9e-01

3.5e-01

6.2e-01

cases:5.34%

controls:4.76%

cases:3.59%

controls:2.74%

—

cases:0.65%

controls:0.36%

cases:3.42%

controls:2.43%

cases:11.61%

controls:6.60%

517

1029

10352

298

1048

10571

—

1078

10813

257

1018

10309

106

594

807

8400

orphenadrine, combinations
M03BC51 [21604113]

1.7e-01

2.6e-01

—

-1.0e+50

4.7e-01

6.1e-01

cases:3.68%

controls:3.11%

cases:1.10%

controls:0.86%

—

cases:0.00%

controls:0.08%

cases:1.61%

controls:1.01%

cases:5.04%

controls:2.79%

338

1047

10531

1075

10776

—

1085

10843

107

1037

10459

251

867

8743

Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]

1.7e-01

-3.2e-01

—

3.2e-01

6.1e-01

cases:3.86%

controls:3.28%

cases:0.74%

controls:1.01%

—

cases:1.14%

controls:0.83%

cases:6.24%

controls:3.48%

356

1045

10513

110

1079

10759

—

1042

10478

313

856

8681

Medical doctor
Z2221 [2001311556]

3.0e-01

5.3e-01

8.8e-01

—

6.8e-01

6.1e-01

cases:5.80%

controls:4.37%

cases:2.21%

controls:1.31%

cases:0.55%

controls:0.23%

—

cases:2.47%

controls:1.27%

cases:5.81%

controls:3.24%

475

1024

10394

142

1063

10727

1081

10844

—

134

1028

10432

291

860

8703

paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]

3.0e-01

5.1e-01

—

-1.0e+50

6.1e-01

cases:4.60%

controls:3.45%

cases:1.56%

controls:0.95%

—

cases:0.00%

controls:0.09%

cases:1.99%

controls:1.10%

cases:5.37%

controls:2.99%

375

1037

10494

103

1070

10766

—

1085

10842

116

1033

10450

269

864

8725

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

1.1e-02

1.9e-01

—

8.0e-01

3.4e-01

6.0e-01

cases:1.66%

controls:1.64%

cases:1.29%

controls:1.07%

—

cases:0.55%

controls:0.25%

cases:1.42%

controls:1.02%

cases:4.38%

controls:2.45%

178

1069

10691

116

1073

10753

—

1079

10825

108

1039

10458

220

873

8774

pH of Serum or Plasma
2753-2 [3018418]

2.0e-01

7.1e-02

—

6.5e-01

4.2e-01

5.9e-01

cases:5.34%

controls:4.42%

cases:2.76%

controls:2.58%

—

cases:0.83%

controls:0.43%

cases:3.89%

controls:2.60%

cases:10.95%

controls:6.39%

480

1029

10389

280

1057

10589

—

1076

10805

275

1013

10291

100

575

813

8419

buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]

5.4e-01

3.3e-01

4.2e-01

—

5.6e-01

4.5e-01

5.9e-01

cases:2.76%

controls:1.62%

cases:1.47%

controls:1.07%

cases:0.64%

controls:0.42%

—

cases:0.74%

controls:0.42%

cases:1.99%

controls:1.28%

cases:4.49%

controls:2.55%

176

1057

10693

116

1071

10753

1080

10823

—

1077

10806

135

1033

10431

229

872

8765

montelukast; oral
R03DC03 [21603356]

5.8e-01

4.6e-01

5.1e-01

—

7.0e-01

5.2e-01

5.1e-01

cases:4.42%

controls:2.51%

cases:2.58%

controls:1.64%

cases:0.74%

controls:0.44%

—

cases:0.83%

controls:0.41%

cases:2.85%

controls:1.71%

cases:5.04%

controls:3.10%

273

1039

10596

178

1059

10691

1079

10821

—

1076

10807

181

1024

10385

279

867

8715

Cough
R05 [45606792]

3.7e-01

1.8e-01

—

1.7e-01

5.8e-01

cases:3.22%

controls:2.24%

cases:1.01%

controls:0.85%

—

cases:1.04%

controls:0.88%

cases:5.04%

controls:2.88%

244

1052

10625

1076

10777

—

1043

10473

259

867

8735

ispaghula (psylla seeds); oral
A06AC01 [21600555]

3.4e-01

2.4e-01

—

1.6e-01

5.2e-01

5.7e-01

cases:5.06%

controls:3.66%

cases:2.58%

controls:2.03%

—

cases:0.55%

controls:0.47%

cases:3.61%

controls:2.18%

cases:7.67%

controls:4.48%

398

1032

10471

221

1059

10648

—

1079

10801

230

1016

10336

403

843

8591

chlorphenamine, combinations
R06AB54 [21603468]

5.7e-01

-5.0e-01

—

-1.0e+50

4.8e-01

2.9e-01

cases:4.05%

controls:2.33%

cases:0.46%

controls:0.75%

—

cases:0.00%

controls:0.08%

cases:0.85%

controls:0.53%

cases:2.41%

controls:1.81%

253

1043

10616

1082

10787

—

1085

10843

1045

10510

163

891

8831

brompheniramine, combinations
R06AB51 [21603466]

5.7e-01

-5.0e-01

—

-1.0e+50

4.8e-01

2.9e-01

cases:4.05%

controls:2.33%

cases:0.46%

controls:0.75%

—

cases:0.00%

controls:0.08%

cases:0.85%

controls:0.53%

cases:2.41%

controls:1.81%

253

1043

10616

1082

10787

—

1085

10843

1045

10510

163

891

8831

phenylephrine, combinations
R01BA53 [21603214]

5.7e-01

-5.0e-01

—

-1.0e+50

4.8e-01

2.9e-01

cases:4.05%

controls:2.33%

cases:0.46%

controls:0.75%

—

cases:0.00%

controls:0.08%

cases:0.85%

controls:0.53%

cases:2.41%

controls:1.81%

253

1043

10616

1082

10787

—

1085

10843

1045

10510

163

891

8831

salmeterol and fluticasone
R03AK06 [21603280]

4.7e-01

3.8e-01

5.7e-01

—

5.6e-01

5.1e-01

5.7e-01

cases:4.05%

controls:2.57%

cases:3.04%

controls:2.10%

cases:1.20%

controls:0.68%

—

cases:1.11%

controls:0.64%

cases:3.42%

controls:2.08%

cases:5.81%

controls:3.37%

279

1043

10590

228

1054

10641

1074

10795

—

1073

10783

220

1018

10346

303

860

8691

lansoprazole; oral
A02BC03 [21600098]

3.7e-01

5.7e-01

7.2e-01

—

6.2e-01

5.0e-01

3.4e-01

cases:6.90%

controls:4.85%

cases:4.05%

controls:2.34%

cases:0.92%

controls:0.45%

—

cases:0.92%

controls:0.50%

cases:3.61%

controls:2.21%

cases:6.46%

controls:4.70%

527

1012

10342

254

1043

10615

1077

10820

—

1075

10798

234

1016

10332

423

854

8571

Dyspnoea
R06.0 [45558449]

1.1e-01

-7.8e-03

—

2.8e-01

5.7e-01

cases:3.31%

controls:2.98%

cases:1.20%

controls:1.21%

—

cases:1.42%

controls:1.08%

cases:6.90%

controls:4.04%

324

1051

10545

131

1074

10738

—

114

1039

10452

363

850

8631

Low back pain
M54.5 [45553207]

3.1e-01

3.9e-01

8.7e-01

—

1.4e-01

5.7e-01

cases:6.26%

controls:4.65%

cases:2.39%

controls:1.63%

cases:0.46%

controls:0.19%

—

cases:1.99%

controls:1.74%

cases:9.64%

controls:5.71%

505

1019

10364

177

1061

10692

1082

10848

—

184

1033

10382

514

825

8480

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

9.8e-02

-7.5e-02

—

3.7e-01

5.6e-01

cases:2.94%

controls:2.68%

cases:1.20%

controls:1.29%

—

cases:1.99%

controls:1.39%

cases:7.23%

controls:4.25%

291

1055

10578

140

1074

10729

—

147

1033

10419

382

847

8612

Angiography of heart and/or coronary arteries
FN1AC [2001302996]

2.4e-01

6.1e-02

-1.0e+50

—

-1.0e+50

4.4e-01

5.6e-01

cases:4.14%

controls:3.29%

cases:1.10%

controls:1.04%

cases:0.00%

controls:0.08%

—

cases:0.00%

controls:0.08%

cases:1.14%

controls:0.74%

cases:5.26%

controls:3.07%

358

1042

10511

113

1075

10756

1087

10860

—

1085

10843

1042

10488

276

865

8718

erdosteine; oral
R05CB15 [21603394]

3.0e-01

6.9e-01

—

7.8e-01

5.5e-01

cases:2.67%

controls:1.99%

cases:1.29%

controls:0.65%

—

cases:1.99%

controls:0.93%

cases:5.04%

controls:2.96%

216

1058

10653

1073

10798

—

1033

10468

266

867

8728

Plugged feeling ear
H13 [2002000480]

3.3e-01

4.5e-01

—

1.6e-01

5.5e-01

cases:3.50%

controls:2.55%

cases:1.47%

controls:0.95%

—

cases:1.14%

controls:0.97%

cases:5.91%

controls:3.49%

277

1049

10592

103

1071

10766

—

103

1042

10463

314

859

8680

Foot/toe symptom/complaint
L17 [2002000641]

2.3e-01

4.8e-01

—

3.2e-01

5.5e-01

cases:4.14%

controls:3.32%

cases:1.93%

controls:1.21%

—

cases:1.90%

controls:1.39%

cases:7.45%

controls:4.45%

361

1042

10508

131

1066

10738

—

147

1034

10419

400

845

8594

Asthma, unspecified
J45.9 [45562456]

2.7e-01

3.7e-01

5.4e-01

—

8.9e-01

4.8e-01

5.5e-01

cases:3.86%

controls:2.97%

cases:2.21%

controls:1.54%

cases:0.64%

controls:0.38%

—

cases:0.74%

controls:0.30%

cases:2.37%

controls:1.49%

cases:6.02%

controls:3.58%

323

1045

10546

167

1063

10702

1080

10828

—

1077

10819

157

1029

10409

322

858

8672

Telephone prescription or other care instructions
WZB00 [2001310884]

1.6e-01

4.4e-01

-1.0e+50

—

-9.4e-02

5.4e-01

cases:3.77%

controls:3.22%

cases:1.56%

controls:1.01%

cases:0.00%

controls:0.10%

—

cases:1.04%

controls:1.15%

cases:5.81%

controls:3.47%

350

1046

10519

110

1070

10759

1087

10858

—

121

1043

10445

312

860

8682

Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]

2.7e-01

2.4e-01

1.0e+00

—

5.6e-01

-7.6e-02

5.3e-01

cases:7.91%

controls:6.13%

cases:3.13%

controls:2.47%

cases:0.92%

controls:0.33%

—

cases:0.65%

controls:0.37%

cases:2.37%

controls:2.56%

cases:10.51%

controls:6.45%

666

1001

10203

269

1053

10600

1077

10833

—

1078

10812

270

1029

10296

580

817

8414

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

644

4356

2.17

33.35

3.1

2.8

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

453

3075

1.81

19.38

2.7

2.5

—

(3032080) INR in Blood by Coagulation assay

614

4683

1.71

16.49

17.0

16.0

1.29

inr

0.06

505

3897

(3013826) Glucose [Moles/volume] in Serum or Plasma

714

5677

1.75

16.47

5.9

5.1

6.40

6.75

mmol/l

5.88

693

5404

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

375

2579

1.69

14.24

2.4

2.2

2.89

2.86

mg/l

0.09

328

2195

(3031040) Bacteria [#/volume] in Urine by Automated count

756

6225

1.70

14.14

6.0

4.9

1556.89

2480.31

e6/l

0.41

118

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

418

2996

1.64

13.33

3.4

2.4

60.31

88.59

u/l

0.53

381

2761

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

582

4533

1.61

13.13

7.5

6.4

1.21

mmol/l

0.63

541

4166

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

984

8894

2.08

11.95

22.1

16.6

26.07

25.43

mg/l

0.22

856

7370

(3013650) Neutrophils [#/volume] in Blood by Automated count

663

5416

1.57

11.52

9.2

9.5

4.14

4.18

e9/l

0.16

578

4671

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

629

5084

1.56

11.40

7.0

6.5

10.92

11.61

umol/l

1.30

595

4840

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

331

2311

1.62

11.35

2.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

804

6935

1.61

10.48

5.2

4.3

11.09

13.28

mm/h

5.32

760

6446

(3024561) Albumin [Mass/volume] in Serum or Plasma

556

4436

1.52

10.24

5.7

4.8

35.22

35.29

g/l

0.11

521

4154

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

111

578

2.02

10.19

9.3

10.9

16.20

15.81

0.66

104

553

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

620

5069

1.52

10.11

8.3

7.1

1.21

mmol/l

0.10

541

4344

(3001122) Ferritin [Mass/volume] in Serum or Plasma

537

4287

1.50

9.65

3.4

3.0

118.99

135.87

ug/l

0.73

501

3954

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

832

7291

1.59

9.57

9.6

8.1

77.44

80.26

u/l

1.04

796

6865

(3019550) Sodium [Moles/volume] in Serum or Plasma

1002

9257

2.01

9.27

25.9

20.1

139.47

139.64

mmol/l

1.29

991

9052

(3023103) Potassium [Moles/volume] in Serum or Plasma

1003

9270

2.02

9.26

26.0

20.3

4.00

3.98

mmol/l

0.75

990

9049

(3015736) pH of Urine

499

3958

1.48

9.06

4.5

3.6

6.28

6.25

0.18

283

2200

(3019977) pH of Arterial blood

186

1185

1.69

8.91

7.5

8.2

7.43

7.42

1.14

654

(3016502) Oxygen saturation in Arterial blood

171

1070

1.71

8.75

7.0

8.4

94.82

95.34

0.36

165

1033

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

185

1194

1.66

8.41

7.5

8.1

4.97

5.09

kpa

1.01

176

1145

(3027801) Oxygen [Partial pressure] in Arterial blood

185

1195

1.66

8.38

7.5

8.1

11.53

11.89

kpa

0.51

176

1149

(3009261) Glucose [Presence] in Urine by Test strip

608

5061

1.45

8.33

5.0

4.1

0.00

0.01

estimate

1.20

109

1048

(3019198) Lymphocytes [#/volume] in Blood

594

4924

1.45

8.32

6.5

5.9

1.79

1.94

e9/l

1.47

529

4260

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

250

1743

1.56

8.25

1.9

—

(3003396) Base excess in Arterial blood by calculation

182

1181

1.65

8.08

7.3

8.1

1.00

1.05

mmol/l

0.05

149

960

(3035350) Ketones [Presence] in Urine by Test strip

602

5019

1.44

8.07

5.1

4.1

0.00

3.14

estimate

0.80

109

1116

(3013115) Eosinophils [#/volume] in Blood

598

4983

1.44

8.02

6.7

6.1

0.20

0.19

e9/l

0.06

530

4284

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1008

9411

1.93

7.82

14.2

12.3

23.06

24.97

u/l

2.34

987

9097

(3006315) Basophils [#/volume] in Blood

581

4835

1.43

7.73

6.5

5.9

0.04

e9/l

0.70

500

4090

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1014

9500

1.95

7.57

28.2

22.2

78.25

78.80

umol/l

0.20

1006

9373

(3019150) Specific gravity of Urine by Refractometry

298

2195

1.49

7.54

5.6

4.2

1.02

kg/l

1.25

208

1481

(3021960) Folate [Moles/volume] in Serum or Plasma

384

2977

1.45

7.45

1.9

1.7

20.57

20.59

nmol/l

0.01

322

2496

(3001604) Monocytes [#/volume] in Blood

578

4825

1.42

7.44

6.5

5.9

0.59

e9/l

0.25

499

4074

(3007461) Platelets [#/volume] in Blood

1025

9646

2.04

7.43

32.8

25.5

246.94

248.75

e9/l

0.40

1009

9429

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1025

9647

2.03

7.41

32.6

25.4

91.65

91.48

0.64

1020

9517

(3021601) Nitrite [Presence] in Urine by Test strip

593

4976

1.42

7.40

5.2

4.0

0.00

estimate

0.50

109

1085

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

474

3823

1.42

7.39

5.0

3.9

34.88

73.39

ng/l

1.24

351

2848

(3026361) Erythrocytes [#/volume] in Blood

1025

9649

2.03

7.37

32.7

25.4

4.39

4.43

e12/l

2.12

1008

9395

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

283

2072

1.49

7.35

1.9

1.7

1.19

1.29

mg/l

0.31

221

1626

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

194

1311

1.58

7.26

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

263

1902

1.50

7.23

4.9

4.0

253.12

372.13

ng/l

0.69

216

1561

(40761511) CBC panel - Blood by Automated count

982

9131

1.76

7.22

20.3

15.0

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1024

9649

2.00

7.15

33.3

26.0

39.83

39.87

0.12

1019

9514

(3035941) MCH [Entitic mass]

1024

9649

2.00

7.15

32.6

25.4

30.40

30.38

0.11

1019

9518

(3010813) Leukocytes [#/volume] in Blood

1024

9650

2.00

7.13

32.8

25.5

6.72

6.81

e9/l

0.27

1007

9393

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

408

3221

1.43

7.09

3.5

3.1

1536.60

1394.50

ng/l

0.36

365

2780

(3007853) Bacteria identified in Skin by Aerobe culture

167

1104

1.61

6.84

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

363

2827

1.43

6.73

4.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

131

820

1.68

6.65

3.2

3.1

193.64

204.79

ng/l

0.15

118

760

(3019309) Folate [Moles/volume] in Red Blood Cells

242

1748

1.49

6.64

1.7

1.8

1224.29

1168.44

nmol/l

0.38

185

1297

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

590

5006

1.39

6.56

3.0

2.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

182

1244

1.56

6.44

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

529

4421

1.38

6.39

2.7

2.4

82.03

78.97

nmol/l

1.53

473

3945

(42870588) Differential panel, method unspecified - Blood

408

3269

1.40

6.34

6.6

5.8

—

(3018010) Neutrophils/Leukocytes in Blood

533

4481

1.37

6.10

6.7

6.0

58.14

57.85

0.21

513

4261

(40768804) Tissue Pathology biopsy report

455

3742

1.37

5.93

2.3

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

945

8786

1.56

5.92

5.5

5.4

5.78

6.00

mmol/l

6.95

874

7976

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

159

1075

1.56

5.89

4.2

5.02

16.65

ug/l

1.67

133

883

(3002030) Lymphocytes/Leukocytes in Blood

541

4575

1.36

5.89

6.7

6.1

26.68

26.93

0.19

516

4312

(3019069) Monocytes/Leukocytes in Blood

532

4492

1.36

5.83

6.8

6.2

9.04

8.94

0.35

505

4185

(3018418) pH of Serum or Plasma

384

3080

1.38

5.81

4.6

4.1

7.39

7.40

0.77

280

2232

(3000991) Gas panel - Venous blood

134

874

1.61

5.78

7.2

9.1

—

(3006504) Eosinophils/Leukocytes in Blood

531

4487

1.36

5.77

6.8

6.1

2.99

2.83

0.70

505

4179

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

389

3133

1.38

5.72

2.3

2.2

353.69

198.55

u/l

0.39

377

2947

(3022096) Basophils/Leukocytes in Blood

531

4491

1.36

5.71

6.9

6.2

0.65

0.68

0.55

505

4177

(3033658) Prothrombin time (PT) actual/Normal

312

2425

1.40

5.68

5.2

4.0

89.69

88.60

0.34

301

2374

(3008152) Bicarbonate [Moles/volume] in Arterial blood

104

642

1.69

5.57

8.8

6.6

24.31

24.42

mmol/l

0.12

610

(3015377) Calcium [Moles/volume] in Serum or Plasma

432

3556

1.36

5.48

3.5

2.36

mmol/l

0.21

387

3213

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

112

710

1.64

5.42

1.6

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

356

2854

1.37

5.31

5.4

4.1

0.00

0.01

estimate

0.96

103

1001

(3039000) Anion gap in Blood by calculation

204

2.15

5.13

7.7

7.2

11.41

11.23

mmol/l

0.13

180

(3018572) Chloride [Moles/volume] in Blood

204

2.15

5.13

7.7

7.2

104.46

105.38

mmol/l

0.45

180

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

218

1623

1.43

5.00

1.3

15.53

13.07

u/ml

0.15

601

(3042936) Bacteria identified in Isolate by Culture

189

1371

1.46

4.98

2.5

2.0

—

(40768797) Stomach Pathology biopsy report

169

1200

1.48

4.96

1.2

—

(40758558) Short blood count panel - Blood

355

2874

1.35

4.89

6.4

6.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

116

762

1.58

4.87

3.1

2.7

67.02

63.25

ml/min/173m2

0.59

344

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

448

3758

1.33

4.84

5.4

4.1

0.06

0.03

estimate

0.34

891

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

152

1065

1.50

4.76

3.1

2.6

7.45

7.07

umol/l

0.06

130

942

(3047181) Lactate [Moles/volume] in Blood

303

1.89

4.69

7.0

6.1

1.26

1.30

mmol/l

0.11

262

(3018095) Leukocytes [#/volume] in Urine

436

3662

1.32

4.60

4.3

4.0

99.05

87.79

e6/l

0.17

316

2616

(3002582) Erythrocytes [#/volume] in Urine

394

3263

1.32

4.60

3.7

3.3

40.59

87.09

e6/l

1.06

305

2521

(3004789) Transferrin [Mass/volume] in Serum or Plasma

208

1575

1.40

4.30

2.8

2.5

2.33

2.27

g/l

0.71

193

1459

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

268

2115

1.35

4.29

1.8

452.58

21824917.71

pmol/l

1.75

226

1732

(3022948) Iron [Moles/volume] in Serum or Plasma

220

1684

1.38

4.26

2.8

2.5

12.89

12.94

umol/l

0.03

203

1558

(3007930) Methemoglobin/Hemoglobin.total in Blood

432

1.69

4.06

7.5

5.0

0.92

0.86

0.53

405

(3000850) Epithelial cells [#/volume] in Urine

287

2306

1.33

4.05

2.9

2.6

4.68

5.70

e6/l

0.64

267

2100

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

356

1.76

4.05

2.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

516

4490

1.28

4.00

2.3

2.2

93.63

95.66

pmol/l

0.40

265

2293

(3027945) Reticulocytes/Erythrocytes in Blood

161

1182

1.42

3.96

2.6

2.7

1.67

1.85

1.87

148

1055

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

344

1.76

3.93

4.2

2.5

0.42

0.36

iu/ml

0.69

185

(3003458) Phosphate [Moles/volume] in Serum or Plasma

186

1404

1.39

3.90

5.8

5.2

1.03

mmol/l

0.05

173

1296

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

799

7368

1.32

3.87

25.4

20.9

13.81

13.73

0.99

792

7254

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

951

9009

1.43

3.85

6.1

2.63

2.65

mmol/l

0.24

885

8285

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

654

5886

1.28

3.77

3.8

3.2

40.34

50.01

u/l

3.01

616

5475

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

152

1116

1.42

3.74

9.2

7.0

—

(3030467) Casts [#/volume] in Urine by Automated count

337

2797

1.30

3.72

3.5

3.2

0.43

0.46

e6/l

0.12

252

2071

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

898

8441

1.36

3.68

6.1

5.5

1.97

1.96

mu/l

0.08

837

7754

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

253

2022

1.33

3.67

1.3

1.65

1.68

u/ml

0.01

537

(3012544) pH of Venous blood

145

1064

1.42

3.58

4.5

3.3

7.37

7.38

0.62

606

(3026008) Bacteria identified in Urine by Culture

373

3150

1.28

3.57

3.7

3.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

220

1730

1.34

3.56

3.1

2.9

1.07

1.14

e6/l

0.14

114

924

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

668

1.51

3.53

1.6

1.7

—

(3044889) 12 lead EKG panel

722

6606

1.27

3.50

5.0

4.3

—

6313.75

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

219

1725

1.34

3.50

1.3

43.36

36.42

iu/ml

0.25

541

(36304419) Bacteria [Presence] in Urine

318

2640

1.29

3.46

3.4

3.2

—

0.00

estimate

—

(3045414) Leukocytes [Presence] in Urine

130

943

1.43

3.42

2.1

0.00

0.03

estimate

0.78

185

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.41

3.41

1.9

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.74

3.33

2.9

1.5

67.06

86.49

umol/l

3.27

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

157

1188

1.38

3.24

3.7

4.5

241.51

251.10

u/l

0.33

146

1122

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

279

2297

1.29

3.22

5.8

4.7

22.27

21.76

0.24

145

1184

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.82

3.19

4.1

2.8

0.59

0.60

mmol/l

0.26

(3006576) Bicarbonate [Moles/volume] in Blood

3.82

3.19

5.5

7.0

24.55

26.38

mmol/l

0.65

(3012095) Magnesium [Moles/volume] in Serum or Plasma

213

1697

1.32

3.13

3.3

3.1

0.82

mmol/l

0.08

199

1592

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

768

7121

1.27

3.12

5.0

4.4

15.01

14.91

pmol/l

0.51

705

6480

(3013512) EKG study

401

3461

1.25

3.11

4.0

3.7

—

0.88

—

(4034850) Laboratory test

269

1.74

3.09

11.8

10.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

168

1298

1.35

3.04

1.6

1.5

—

(3044941) Cell count panel - Synovial fluid

176

1.90

2.98

1.2

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.85

2.92

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.85

2.92

3.1

2.2

359.15

651.45

e6/l

0.79

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

334

2840

1.25

2.92

6.3

5.7

2.35

2.92

ug/l

0.69

305

2529

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

488

1.53

2.91

2.2

2.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.21

2.84

2.0

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

928

8847

1.33

2.82

5.4

5.3

4.63

4.60

mmol/l

0.47

869

8173

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

476

1.53

2.81

7.5

4.7

1.75

1.54

1.39

448

(3000494) Fungus identified in Specimen by Culture

153

1182

1.34

2.78

1.7

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

233

1.74

2.75

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

184

1462

1.31

2.75

2.9

2.6

21.91

22.85

0.44

171

1358

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

5.02

2.73

8.0

7.3

10.41

10.44

—

(3045424) Erythrocytes [Presence] in Urine

471

1.52

2.73

2.3

2.0

0.00

1.83

estimate

0.50

137

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

361

3116

1.24

2.73

4.7

3.1

32.56

33.41

u/l

0.10

337

2929

(3005322) IgE [Units/volume] in Serum or Plasma

605

1.46

2.70

1.2

1.3

126.26

201.70

u/ml

1.05

555

(3043410) Blood group antigens tested for on Red Blood Cells

3.47

2.69

1.8

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

922

8797

1.31

2.67

5.4

5.2

1.57

1.49

mmol/l

6.46

857

8061

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

274

1.67

2.65

1.2

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

885

8403

1.28

2.64

4.5

4.4

1.16

1.28

mmol/l

5.85

816

7627

(3018677) aPTT in Platelet poor plasma by Coagulation assay

190

1526

1.30

2.62

2.4

2.1

29.35

29.72

0.42

185

1488

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

120

902

1.37

2.60

2.2

2.3

32.13

36.52

u/l

0.96

107

746

(3042733) HLA Ab [Presence] in Serum

3.62

2.57

2.7

4.0

—

(3002619) Bacteria identified in Specimen by Culture

3.62

2.57

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

4.02

2.57

7.2

6.0

5.15

5.36

kpa

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.17

2.55

1.0

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.62

2.53

3.1

2.4

198.31

239.12

e6/l

0.42

(3006571) Granulocytes/Leukocytes in Synovial fluid

108

2.06

2.53

1.3

1.4

61.91

63.23

0.04

(3028433) Virus identified in Specimen by Culture

3.48

2.48

1.1

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

383

1.54

2.48

1.8

1.9

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

2.26

2.45

2.5

3.5

13.12

13.34

0.41

(3048689) Calprotectin [Mass/mass] in Stool

140

1089

1.33

2.44

2.2

151.22

125.14

ug/g

0.38

118

860

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

189

1.77

2.43

6.7

5.7

255.30

194.68

iu/ml

—

(3023520) Reticulocytes [#/volume] in Blood

119

905

1.35

2.41

2.1

2.8

64.31

70.06

e9/l

1.27

655

(3026493) Urate [Moles/volume] in Serum or Plasma

291

2489

1.23

2.35

2.7

334.53

346.53

umol/l

1.21

248

2174

(3047007) Chlamydophila sp Ab [Presence] in Serum

112

1.98

2.31

1.3

—

(3051651) Icteric interference index of Serum or Plasma

2.47

2.28

2.5

3.3

0.92

0.83

index

0.23

(3002032) Base excess in Venous blood by calculation

131

1021

1.32

2.26

4.2

3.2

1.70

1.96

mmol/l

0.36

113

866

(3003327) Ova and parasites identified in Stool by Light microscopy

291

1.57

2.14

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.22

2.09

7.4

6.0

6.36

6.10

kpa

—

(3017732) Neutrophils [#/volume] in Blood

147

1177

1.29

2.09

3.6

3.2

5.57

5.35

e9/l

0.06

128

1002

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

124

1.87

2.08

1.3

1.2

6.18

5.68

u/ml

0.05

(3022145) Colonoscopy Study observation

133

1052

1.30

2.08

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

908

8712

1.25

2.06

20.3

16.5

77.00

77.22

ml/min/173m2

0.12

849

8078

(3026389) Candida sp identified in Specimen by Organism specific culture

103

1.96

2.06

1.2

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

898

8606

1.25

2.06

6.2

6.8

38.67

39.80

mmol/mol

5.03

838

7991

(40760892) CBC W Ordered Manual Differential panel - Blood

242

2058

1.23

2.05

5.4

4.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

125

1.86

2.03

1.3

1.2

15.56

3.22

u/ml

—

(3037522) Nuclear Ab [Titer] in Serum

158

1282

1.27

2.03

1.4

1.3

291.58

504.50

titre

3.72

302

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.83

2.00

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.20

1.95

1.6

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.20

1.95

1.6

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

356

1.48

1.94

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

406

1.45

1.93

2.9

3.6

616.36

3159.59

u/ml

0.52

350

(3020779) Urea [Moles/volume] in Serum or Plasma

118

931

1.30

1.89

8.8

6.8

10.67

10.65

mmol/l

0.01

110

893

(3042631) Mycobacterium sp identified in Specimen

151

1.74

1.88

1.6

2.5

—

(3019225) pH of Specimen

118

934

1.30

1.85

4.5

4.2

7.37

0.10

657

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

191

1604

1.23

1.82

3.2

3.0

3.00

2.37

e6/l

0.28

789

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.18

1.82

1.0

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.77

1.79

1.3

1.2

178.44

163.27

pmol/l

—

(3011412) CD3 cells [#/volume] in Blood

2.04

1.75

3.3

2.0

953.60

1175.48

e6/l

0.58

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

125

1.78

1.73

1.5

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.86

1.71

1.2

79.00

90.85

—

(3003694) ABO and Rh group [Type] in Blood

289

2541

1.19

1.71

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

209

1786

1.21

1.69

1.4

1.5

2.61

2.52

g/l

0.12

132

1058

(3041096) Erythrocytes [Presence] in Urine by Automated

301

2662

1.18

1.66

4.5

3.6

0.01

0.02

estimate

0.38

854

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

542

1.35

1.62

4.6

3.5

42.52

47.88

1.21

531

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

136

1.71

1.59

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

597

1.33

1.58

2.3

2.5

27.44

20.21

au/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

215

1.55

1.58

4.8

3.7

24.53

28.60

mg/l

0.31

151

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.01

1.58

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.28

1.55

1.1

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

104

832

1.28

1.53

4.4

3.8

94.62

89.56

ng/l

0.17

729

(3000570) Elastase.pancreatic [Mass/mass] in Stool

300

1.45

1.51

1.8

1.4

260.10

280.75

ug/g

0.31

180

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.87

1.51

1.1

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.96

1.49

1.2

1.4

17.93

14.32

u/l

0.33

(3026782) Osmolality of Urine

229

1997

1.19

1.48

3.2

2.9

533.95

528.61

mosm/kgh2o

0.14

204

1744

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

542

1.33

1.48

1.2

1.3

55.18

56.86

au/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

448

1.36

1.45

2.4

1.9

2.58

2.38

ug/l

0.06

397

(4195642) Thrombophilia screening test

104

1.74

1.37

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.62

1.37

2.3

1.0

14.28

16.33

umol/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

105

855

1.25

1.36

2.9

2.4

8.94

6.98

ug/l

0.32

749

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.95

1.36

1.0

1.1

1.18

1.17

mmol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.14

1.34

1.3

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

121

1.67

1.31

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

121

1.67

1.31

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

121

1.67

1.31

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

121

1.67

1.31

1.6

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

509

1.32

1.31

1.6

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

466

1.33

1.29

1.5

1.9

1.55

1.59

g/l

0.13

414

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.80

1.27

1.3

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.80

1.27

1.3

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.80

1.27

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

269

1.43

1.27

1.5

1.6

—

(4015189) Microbial culture of sputum

2.41

1.24

2.0

3.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.23

1.24

1.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.23

1.24

1.3

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.23

1.24

1.3

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

212

1.48

1.24

2.1

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

246

1.44

1.22

2.0

2.2

131.96

127.22

g/l

0.58

201

(3009508) Creatinine [Moles/volume] in Urine

314

3447

0.87

1.22

3.3

3.4

6.75

7.22

mmol/l

1.33

266

2893

(3022621) pH of Urine by Test strip

777

1.24

1.20

2.9

2.7

6.09

6.05

0.20

537

(3052851) Hemolysis interference index of Serum or Plasma

264

1.42

1.20

3.4

3.3

1.60

2.03

index

0.35

136

(4094501) Cardiovascular stress test using bicycle ergometer

239

1.44

1.19

1.1

—

(3024471) HLA-A [Type]

2.31

1.19

1.0

—

(3024932) HLA-DR beta [Type]

2.31

1.19

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.31

1.19

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

117

1.63

1.18

1.1

—

(21494755) Public health laboratory ask at order entry panel

599

0.74

1.18

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

110

1.65

1.16

2.3

2.5

26.67

20.74

mg/l

—

(4268621) Lupus anticoagulant assay

1.73

1.15

2.5

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.34

1.12

3.9

2.4

10.34

9.76

kpa

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.34

1.12

3.0

2.3

103.93

136.03

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.34

1.12

3.9

2.4

4.88

4.76

kpa

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.71

1.11

2.3

2.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

239

2143

1.15

1.09

2.8

2.9

2.45

2.46

mmol/l

0.96

217

1929

(3036489) Thrombin time

331

1.34

1.07

2.1

2.0

21.67

21.00

0.29

302

(3036481) Cortisol [Moles/volume] in Serum or Plasma

107

900

1.21

1.06

3.1

2.1

363.81

381.67

nmol/l

0.38

830

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

744

1.23

1.06

1.8

1.6

—

(3002256) Pathology report gross observation

149

1293

1.18

1.05

1.4

1.3

—

(3005570) Glucose [Moles/volume] in Urine

1.68

1.04

2.9

2.0

—

(3037121) Protein [Mass/volume] in Urine

324

1.34

1.04

3.6

3.0

411.62

281.56

mg/l

0.30

133

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

146

1.52

1.03

1.1

25.58

19.65

au/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

315

3420

0.89

1.00

3.6

4.2

8.60

8.64

mg/mmol

0.01

181

2120

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

213

0.61

1.00

1.4

86.62

320.74

pmol/l

2.00

208

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

1.37

1.00

1.5

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

111

944

1.20

0.99

2.4

2.1

0.21

g/l

0.04

100

880

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.84

0.98

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.64

0.97

1.2

1.3

7954.00

193747.23

e6/l

—

(3033799) Differential panel - Peritoneal fluid

0.00

0.97

0.0

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

108

1.58

0.97

1.1

1.3

—

71.90

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

108

1.58

0.97

1.4

519.22

368.73

u/l

0.37

103

(3012516) Albumin [Mass/volume] in Urine

308

3340

0.89

0.96

3.1

3.5

52.79

45.30

mg/l

0.23

194

2134

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

1.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

1.2

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

1.2

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.77

0.94

1.2

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.66

0.94

1.1

1.2

113.29

107.35

pmol/l

0.15

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.66

0.94

1.1

1.2

16.21

11.29

u/l

0.77

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

110

1.55

0.91

1.0

1.1

1.05

1.85

eliau/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.60

0.91

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

152

0.59

0.89

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

263

1.34

0.88

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.91

0.88

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

127

0.55

0.88

1.6

1.5

281.71

274.68

mosm/kgh2o

—

(3035637) Corticotropin [Mass/volume] in Plasma

111

1.54

0.88

1.4

1.5

23.54

37.46

ng/l

0.66

111

(3006653) Thiamine [Moles/volume] in Blood

1.79

0.88

1.2

1.3

150.20

135.24

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

135

1183

1.16

0.87

4.8

5.0

33.14

32.90

0.10

754

(4024509) Urine culture

470

1.25

0.85

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

239

1.35

0.85

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

635

1.21

0.84

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

417

3922

1.10

0.84

2.0

1.9

1.19

1.32

mmol/l

3.57

354

3242

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

124

1083

1.16

0.84

3.3

3.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.76

0.83

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

114

0.52

0.83

1.8

1.6

55.03

60.30

ug/l

—

(3025941) Bacteria identified in Stool by Culture

472

1.24

0.82

1.3

1.2

—

(3012501) Base excess in Blood by calculation

206

1.37

0.82

4.1

4.7

2.44

2.92

mmol/l

0.43

138

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

1.88

0.82

1.0

1.1

—

76.20

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.65

0.81

1.4

1.3

—

490.00

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

593

1.21

0.80

1.1

1.2

155.36

146.68

u/ml

0.05

231

(3017704) Immunofixation for Urine

1.73

0.79

1.3

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.82

0.79

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

484

1.23

0.79

3.7

3.0

25.21

25.29

mmol/l

0.06

468

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.79

0.0

2.1

—

7.63

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.67

0.79

1.6

1.3

5.00

10.10

u/l

—

(1761868) Lipid panel - Serum or Plasma

307

3292

0.91

0.76

3.5

3.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.77

0.76

1.2

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.77

0.76

1.7

1.4

2.03

1.99

umol/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.76

0.0

1.6

—

96.93

—

(1175426) CD3 cells/Lymphocytes in Blood

1.70

0.76

2.1

1.8

78.70

73.91

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

175

1.38

0.75

1.6

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

158

1.40

0.75

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.09

0.74

1.4

1.7

6.40

6.25

mmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.09

0.74

1.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.09

0.74

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

0.72

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.93

0.70

1.2

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.93

0.70

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.93

0.70

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

0.70

1.0

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

265

1.29

0.70

2.9

2.5

3.33

3.62

g/l

0.65

253

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

328

1.26

0.70

1.3

—

(4146454) Self-monitoring of blood glucose

117

0.60

0.68

1.3

2.7

—

(1616796) Gas panel - Central venous blood

223

1.31

0.67

3.7

3.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.79

0.66

2.2

1.3

10.22

9.34

ug/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

773

0.84

0.65

2.2

2.1

3.25

3.43

ratio

0.63

632

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.58

0.65

1.5

1.3

—

62.00

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

224

1.30

0.65

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.59

0.65

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

103

1.46

0.65

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

147

1.37

0.62

1.5

1.4

112.67

162.72

au/ml

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1.48

0.60

1.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

1.29

0.60

1.3

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.57

0.60

2.5

2.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.60

0.0

5.5

—

8.74

—

(3014891) Appearance of Pleural fluid

0.00

0.60

0.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.60

0.0

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

148

1.36

0.60

1.3

1191.40

1710.51

e6/l

0.68

102

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.54

0.59

1.3

1.1

—

(3014271) Vancomycin [Susceptibility]

1.54

0.59

2.1

2.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.51

0.58

2.3

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

1.31

0.58

1.1

1.5

—

(3023419) Bacteria identified in Sputum by Culture

158

1.34

0.57

4.1

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.49

0.57

1.1

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.51

0.56

2.4

1.6

9.80

13.34

umol/l

2.01

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.45

0.55

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

133

1.36

0.55

1.2

1.4

46963.00

69498.91

e6/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

126

0.63

0.54

1.1

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

222

1.27

0.54

1.4

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

125

1.37

0.54

2.6

6.2

8.73

7.30

mmol/l

0.50

107

(36660697) Celiac disease serology panel - Serum

735

1.14

0.52

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.50

0.51

1.3

73.83

57.88

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.42

0.50

1.6

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.42

0.50

2.3

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.47

0.50

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

261

1.23

0.50

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1.27

0.48

1.3

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.45

0.48

1.2

2.6

1.00

1.53

u/field

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

598

1.15

0.48

1.3

—

(3024263) Appearance of Synovial fluid

1.49

0.47

1.0

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

894

1.12

0.46

2.4

2.7

66.09

66.56

g/l

0.30

828

(3016038) Potassium [Moles/volume] in Urine

0.60

0.45

1.2

30.00

35.48

mmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

138

1.31

0.45

1.3

0.61

13.64

nmol/l

0.50

131

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

165

1.28

0.45

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

183

1.26

0.45

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.40

0.44

1.1

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

247

1.22

0.44

4.0

3.4

0.77

0.81

nmol/l

0.25

206

(40768443) Skin Pathology biopsy report

442

1.16

0.44

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

358

1.18

0.44

1.3

1.2

0.18

1.55

u/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.37

0.44

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

202

1.24

0.43

1.0

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

563

0.86

0.43

1.7

1.8

3.43

3.48

mmol/l

0.11

422

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

218

0.78

0.42

1.1

1.2

—

0.68

—

(40768793) Breast Pathology biopsy report

249

1.21

0.42

1.4

1.3

—

(3016228) CD19 cells/cells in Blood

1.52

0.41

2.8

1.5

1.00

7.30

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.47

0.40

1.4

1.3

—

(44813793) Dust mix specific IgE antibody measurement

1.34

0.40

1.1

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

314

0.82

0.40

3.5

2.0

0.00

g/l

-0.00

295

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

104

0.67

0.39

1.6

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

182

0.77

0.39

1.1

1.2

15.43

37.02

u/l

1.07

158

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.43

0.39

1.0

1.1

—

80.11

—

(40765096) Chromosome analysis panel by Banding

1.43

0.39

1.4

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.43

0.39

3.0

1.5

37.00

32.54

—

(3022313) Gas panel - Capillary blood

459

1.14

0.37

5.7

3.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

343

0.84

0.37

3.2

2.0

0.00

0.02

g/l

0.65

308

(3045788) Cell count panel - Pleural fluid

125

1.28

0.37

1.3

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

1.39

0.37

1.0

1.1

—

188.46

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1.39

0.37

1.3

1.2

1.99

2.03

mmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

0.66

0.36

3.8

3.3

14.30

26.50

mg/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

153

1.25

0.35

1.1

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

122

0.74

0.35

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.40

0.35

6.3

1.8

41.68

40.39

g/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

243

0.82

0.34

1.2

1.55

1.58

g/l

0.26

243

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.34

0.33

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

127

1.26

0.33

1.3

1.1

0.91

1.37

u/ml

0.22

(3004716) Salmonella sp identified in Stool by Organism specific culture

413

0.87

0.33

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

117

1090

1.08

0.32

1.6

—

(40768441) Liver Pathology biopsy report

1.35

0.32

2.1

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.28

0.32

9.7

2.7

408.00

1598.60

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

165

1.22

0.31

1.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

0.72

0.31

1.1

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.72

0.31

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

0.71

0.31

2.6

—

(4035726) Immunohistochemistry procedure

880

1.09

0.30

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

419

1.13

0.30

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

1.34

0.30

2.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

120

1.25

0.30

3.7

4.5

—

(3017181) Myelocytes/Leukocytes in Blood

912

1.08

0.29

3.9

4.4

0.62

0.94

1.06

284

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

176

1.20

0.29

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.29

0.28

1.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.29

0.28

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.29

0.28

1.0

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

178

1696

1.06

0.27

3.4

0.87

0.78

ug/l

0.16

119

1169

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

140

1.22

0.27

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

224

1.16

0.27

1.2

1.3

73.09

220.41

miu/ml

5.38

101

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

243

1.16

0.27

1.1

1.2

572.00

497.84

mg/l

0.15

229

(3009343) pH of Capillary blood

665

1.09

0.26

5.0

3.5

7.42

0.26

569

(3024980) IgG subclass 4 [Mass/volume] in Serum

141

1.21

0.26

2.4

1.6

0.73

0.80

g/l

—

117

(40768806) Pleura Pathology biopsy report

123

1.22

0.25

1.5

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.22

0.25

1.0

—

(3006270) Folate [Moles/volume] in Blood

1.22

0.25

1.1

1.2

414.00

373.98

nmol/l

—

(3021440) Promyelocytes/Leukocytes in Blood

871

1.07

0.24

4.1

4.5

0.08

0.11

0.13

244

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

115

1.22

0.23

1.3

0.21

0.19

nmol/l

0.81

(40761536) Microorganisms panel - Urine sediment

786

1.07

0.23

4.6

4.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.32

0.23

1.2

1.8

20.68

6.43

nmol/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.28

0.23

1.0

1.3

5.84

6.47

mmol/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

247

1.14

0.22

1.7

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

146

0.82

0.22

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

353

1.11

0.22

3.5

3.6

34.48

48.56

mg/l

0.72

302

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

135

1.19

0.21

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

585

1.08

0.21

5.0

3.4

1.65

1.90

mmol/l

0.28

450

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.3

—

6.17

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

0.58

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

70.40

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

101

0.79

0.21

1.1

1.2

1.51

1.37

nmol/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.16

0.21

2.0

1.3

27.32

24.47

umol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.16

0.21

1.0

1.1

1939.80

1654.30

miu/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

1.16

0.21

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

644

1.08

0.21

1.3

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

1.11

0.20

3.2

3.4

1.59

4.92

ratio

1.11

177

(1761482) Bacteria [#/volume] in Urine by Culture

259

1.12

0.20

3.9

4.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

2.0

—

19.14

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

355

1.10

0.20

3.5

3.6

39.87

63.23

mg/l

0.72

304

(21494890) Protein electrophoresis panel - 24 hour Urine

114

0.79

0.20

1.8

2.0

—

(4281824) Cell count and differential, peritoneal fluid

114

0.79

0.20

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

250

1.12

0.20

1.9

284.03

4.25

iu/l

0.46

(3035933) Granulocytes/Leukocytes in Blood

218

0.87

0.19

2.7

3.0

57.82

59.18

0.20

218

(3022806) Fractional oxyhemoglobin in Capillary blood

122

0.82

0.19

1.2

2.0

88.70

89.74

—

122

(3004588) Protein electrophoresis panel - Serum or Plasma

725

1.07

0.19

2.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

901

1.06

0.19

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

1.13

0.18

2.7

36.83

42.09

—

(3000330) Specific gravity of Urine by Test strip

522

1.08

0.18

4.4

3.6

1.02

ratio

0.22

481

(3020876) Protein [Mass/time] in 24 hour Urine

119

1.18

0.17

2.0

2.3

2.64

1.52

g/24h

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

957

0.95

0.17

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

291

1.10

0.17

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.11

0.17

1.0

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1.11

0.17

1.0

1.1

176.86

245.23

mg/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.75

0.17

1.2

1.9

87.20

100.19

ng/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.72

0.17

1.8

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

398

1.08

0.16

1.5

2.1

4.26

8.08

iu/ml

0.87

(3018333) Ribosomal P Ab [Presence] in Serum

1.13

0.16

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

172

0.87

0.15

4.9

4.0

1.07

1.39

0.27

153

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.16

0.15

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.13

0.15

1.1

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.15

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

129

0.85

0.14

2.1

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

129

0.85

0.14

2.1

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

129

0.85

0.14

2.1

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.08

0.14

1.6

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.80

0.14

1.6

1.7

—

(3002179) Metamyelocytes/Leukocytes in Blood

861

1.05

0.14

4.0

4.3

0.37

0.72

1.49

259

(3021589) Normoblasts [#/volume] in Blood

431

4245

1.03

0.14

12.3

11.5

0.00

e9/l

0.39

355

3445

(44816559) Phosphatidylethanol [Mass/volume] in Blood

326

0.92

0.14

1.6

1.5

0.19

0.34

mg/l

1.22

132

(1617658) Protocol used for examination of sentinel lymph nodes

1.19

0.14

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

191

0.89

0.14

5.9

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

1.15

0.13

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

1.17

0.13

5.4

4.7

—

(3028707) Methadone [Presence] in Urine by Screen method

0.83

0.13

11.2

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

627

1.06

0.13

2.1

2.3

11.99

13.17

nmol/l

0.55

563

(3027944) Amphetamines [Presence] in Urine

190

0.89

0.13

5.8

1.5

—

(3008898) HLA-B27 [Presence]

277

1.09

0.13

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

137

0.87

0.12

2.0

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

124

1.13

0.11

1.6

1.3

469.93

300.89

pmol/l

0.40

107

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

318

1.07

0.11

2.9

1.7

4.77

3.20

mg/l

0.32

247

(3019832) Treponema pallidum Ab [Presence] in Serum

536

0.95

0.11

1.5

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.15

0.10

1.0

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

269

0.93

0.10

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.10

1.0

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

116

1.12

0.09

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

124

0.89

0.09

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

131

1279

1.03

0.09

1.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

237

0.93

0.09

3.0

2.2

77.74

98.17

ug/min

0.20

138

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.03

0.08

5.8

3.8

1.67

1.21

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.09

0.08

1.7

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.09

0.08

1.7

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

123

0.89

0.08

2.0

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.84

0.07

1.0

—

(1002224) Polysomnography panel

378

0.95

0.07

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

266

0.94

0.07

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.80

0.07

1.0

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.07

0.07

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.04

0.07

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.04

0.07

1.1

—

(3025130) Human papilloma virus identified in Specimen

122

0.90

0.07

1.7

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

122

0.90

0.07

2.0

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

122

0.90

0.07

2.0

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

265

0.94

0.07

1.1

—

(21494434) Karyotype in Bone marrow

1.12

0.07

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.89

0.06

1.1

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

1.11

0.06

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

375

0.96

0.06

1.9

1.7

—

(3037756) Immunofixation for Serum or Plasma

233

0.94

0.06

1.3

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

940

1.02

0.05

2.4

1.7

1.45

1.49

0.23

807

(3028300) Cannabinoids [Presence] in Urine

192

0.94

0.05

5.7

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.11

0.05

1.1

—

(3000012) Reticulocyte production index

161

0.93

0.05

1.3

2.3

0.91

—

117

(3016879) Cocaine [Presence] in Urine

181

0.94

0.05

5.8

1.5

—

(3027008) Opiates [Presence] in Urine

191

0.94

0.04

5.7

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

140

0.93

0.04

7.2

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

109

0.92

0.04

1.8

1.5

—

(3021901) Oxygen saturation in Capillary blood

230

0.96

0.03

3.5

2.7

85.92

89.16

0.73

222

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

260

1.04

0.03

1.4

1.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

270

0.96

0.03

3.5

2.8

7.36

7.93

kpa

1.04

265

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

608

1.02

0.03

1.8

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

231

1.04

0.02

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

291

1.03

0.02

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

152

1.05

0.02

6.1

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

228

0.96

0.02

1.1

—

(3025159) Blasts/Leukocytes in Blood

880

1.01

0.02

4.6

4.7

2.13

0.17

0.43

229

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

135

1340

1.01

0.01

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

552

1.02

0.01

1.7

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

203

1.04

0.01

1.0

1.3

1.38

22.73

e6/l

0.75

156

(3003181) Sodium [Moles/volume] in Urine

227

0.97

0.01

1.3

1.4

67.19

63.12

mmol/l

0.17

180

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

253

1.03

0.01

1.7

1.2

0.85

0.92

g/l

0.85

253

(3038515) Glucose [Moles/volume] in Venous blood

234

1.03

0.00

3.3

3.0

7.24

7.57

mmol/l

0.35

229

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

254

1.02

0.00

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

316

0.98

0.00

1.5

1.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

104

0.96

0.00

1.3

1.2

7.51

7.58

mmol/l

—

(40768795) Lymph node Pathology biopsy report

106

1.04

0.00

1.5

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

214

0.98

0.00

2.0

2.6

17.08

15.90

1.02

209

(3017354) Segmented neutrophils/Leukocytes in Blood

108

1.02

0.00

4.2

3.9

52.05

56.59

0.24

(3009466) Valproate [Moles/volume] in Serum or Plasma

138

1.01

0.00

5.2

5.4

355.43

363.03

umol/l

0.09

124

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

168

1.01

0.00

1.4

2.2

14605.50

2886.31

u/l

—

(3049717) Cytology report of Urine Cyto stain

388

1.01

0.00

2.6

2.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

291

1.00

0.00

1.6

1.5

0.08

0.11

iu/ml

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

359

1.00

0.00

6.2

3.7

24.43

24.84

mmol/l

0.45

333

(3009445) Proteinase 3 Ab [Units/volume] in Serum

401

1.00

0.00

1.8

1.6

—

12.65

—

(3003740) Influenza virus B Ag [Presence] in Specimen

127

1.02

0.00

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

127

1.02

0.00

1.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

173

0.98

0.00

2.9

3.0

4.93

4.35

e9/l

0.49

173

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

203

0.98

0.00

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

203

0.98

0.00

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

343

0.99

0.00

1.7

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

275

0.98

0.00

3.2

2.9

1.41

1.61

mmol/l

1.14

270

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

155

1.03

0.00

1.1

1.2

279.91

274.64

u/ml

0.03

(3012441) Differential panel - Pleural fluid

125

1.04

0.00

1.2

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.0

16.2

—

0.20

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

0.02

—

(3004451) EKG impression Narrative

0.99

0.00

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.88

-0.00

2.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

39.04

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3045142) Bone marrow Pathology biopsy report

120

1.00

-0.00

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.98

-0.00

1.4

1.5

1.57

3.15

ug/l

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

0.08

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.0

1.6

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

8.16

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

3.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.2

—

29.40

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.97

-0.00

1.0

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.93

-0.00

1.0

1.1

320.57

281.70

mg/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.91

-0.00

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

22.36

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

4.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.97

-0.00

1.3

2.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

110

1.00

-0.00

1.4

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.92

-0.00

1.6

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

0.08

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

21.50

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

383.40

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint HERING_UNILATERAL and mortality.

Females

Parameter	HR [95% CI]	p-value
HERING_UNILATERAL	1.295 [1.16, 1.44]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.062

During the follow-up period (1.1.1998 — 31.12.2019), 1286 out of 4333 females with HERING_UNILATERAL died.

Males

Parameter	HR [95% CI]	p-value
HERING_UNILATERAL	1.073 [0.95, 1.21]	0.246
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 809 out of 2808 males with HERING_UNILATERAL died.

Mortality risk

Mortality risk for people of age

years, who have HERING_UNILATERAL.

N-year risk	Females	Males
1	0.119%	0.186%
5	0.747%	1.151%
10	1.797%	3.065%
15	3.311%	5.71%
20	5.777%	9.605%

Relationships between endpoints

↥

Index endpoint: HERING_UNILATERAL – Inguinal hernia, unilateral

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Inguinal hernia, unilateral

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints